Novel Indicator Platform

Information

  • Patent Application
  • 20120058503
  • Publication Number
    20120058503
  • Date Filed
    May 06, 2010
    14 years ago
  • Date Published
    March 08, 2012
    12 years ago
Abstract
A novel indicator platform comprises a plurality of 1H-lndol-3-yl indicator compounds that are capable of converting to a signalophore compound in response to an external stimulus. In one class of indicator compounds, the resulting signalophores are 2-benzylideneindoline compounds that are formed by an intermolecular Aldol-type process; in a further class of indicator compounds, the resulting signalophores are 10H-indolo[1,2-a]indole compounds that are formed by an intramolecular Aldol-type process. The indicators can be used in a wide array of applications relating, for example, to biological systems or optical data storage.
Description
FIELD OF THE INVENTION

The invention discloses of a new class of chromogenic and fluorogenic indicators responding to external stimuli such as biochemical environment, temperature or photo irradiation. The novel indicators offer broad potential in a wide array of applications relating, for example, to biological systems or optical data storage.


BACKGROUND OF THE INVENTION

Indicators are materials that produce a detectable signal (also denoted “dS”) in response to an external stimulus (also denoted “eS”). Such stimuli typically include temperature, light (photo-labile or photochromic indicators), electric field (electrochromic indicators), pressure (piezoelectric indicators), ion concentration (e.g. pH indicators) and biochemical reactivity (e.g. enzyme indicators).


The mechanism of translation of stimulus into detectable signal is illustrated in Scheme I and typically involves the chemical removal or modification of a labile group (also denoted “LG”) of the indicator in a process mediated by the experience of said stimulus.




embedded image


Removal or modification of the labile group most often yields an activated signalogen (also denoted “aS”) which typically undergoes further transformation which often involves interaction with auxiliary reagents (also denoted “aR”) to yield a signalophore (also denoted “SP”), the formation of which usually coincides with the occurrence of said detectable signal. Therefore, an indicator represents an activated signalogen that is masked, i.e. inactivated by a labile group. An indicator system (also denoted “IS”) comprises the elements of activated signalogen, labile group, auxiliary reagent (optional), detectable signal and suitable means for interrogation of detectable signal. The appearance of a detectable signal is a consequence of experiencing an external stimulus and hence allows ready detection and/or quantification of the external stimulus by interrogation with suitable instrumentation or the human eye.


Examples of detectable signal include change in optical density, absorption or emission (e.g. chromogenic, fluorogenic and luminogenic indicators) or change in electric current or potential (electrogenic indicators).


A detectable signal may be transient or persistent in nature: For example a fluorogenic enzyme indicator may release a fluorescent entity upon experience of certain enzymatic activity. In this case the detectable signal is persistent in nature. In contrast a bioluminogenic indicator may emit light in response to the presence of ATP. The emission of light representing the detectable signal is transient in nature.


A detectable signal may be associated with transient or persistent external stimuli: For example, pH indicators continuously change color in response to changing proton concentrations, which represents a persistent external stimulus. In this case the corresponding indicators undergo reversible change and are termed reversible indicator systems. In contrast a photo-labile indicator may undergo lasting color change in response to a short laser pulse. In this case the corresponding indicators undergo irreversible change upon a single experience of external stimulus and are termed irreversible indicator systems.


There exist a large number of important technical applications including biology, diagnostics, chemistry and optical data storage that relate to irreversible indicators.


Indicators used in biology often respond to enzymatic activity. Enzyme indicators are used in many formats of assay. Such assays may be performed in solution phase which requires a soluble indicator system.


Other assays require the physical location of enzymatic activity. Here, a suitable indicator will stain the specific site associated with enzyme activity. For this purpose the indicator must form an insoluble precipitate in response to localized enzymatic stimuli. These types of indicators are termed insoluble or precipitating indicator systems. Precipitating indicator systems by nature are irreversible.


Detection of enzyme activity is important in diagnostic and testing applications as well as in biochemistry, molecular biology and histology research. In diagnostics, enzyme activity relates to the presence of microbial pathogens, as well as to metabolic ill functions or to genetic disorders.


Immunological methods are based on the interaction of antibodies with antigens. In order to detect such interaction, antibodies must be carrying a label. Enzymes are commonly used to label secondary antibodies. Hence, the detection of enzyme activity is fundamental to immunological assays. Immunological assays are widely used in clinical diagnostics, food and environmental testing, as well as in biochemical protocols such as Western blotting.


In molecular biology the detection of enzyme activity is needed in reporter gene protocols. Genetic expression of a reporter gene gives rise to enzyme activity that can be detected. This way, the researcher obtains information on genetic transformations.


1H-Indox-3-yl Indicator Systems

1H-Indox-3-yl (also denoted “Indox”) indicators are well known chromogenic indicators widely used to visualize enzymatic activity in microbiology, immunology, biochemistry and genetics.


Indox indicator systems are derived from the 1H-indol-3-ol (3-hydroxyindol, respectively its tautomeric form indolin-3-one or 3-oxoindoline, denoted Indoxol) structure where the hydrogen atom of the 3-hydroxyl group is replaced by a labile group. Loss of the labile group yields Indoxol as an activated signalogen which interacts with atmospheric oxygen (a common auxiliary reagent) in a complex radical chain reaction to yield colloidal indigo stains as signalophor. A dramatic change in optical transmission of a sample associated with indigo dye formation represents a detectable signal of the indicator system.


Despite their widespread use and commercial significance, applications of Indox indicator systems suffer from some major limitations:


For instance, Indox indicator systems depend on molecular oxygen or other oxidizing auxiliary reagents to develop desired indigo signalophores. Due to said requirement indoxyl substrates are of limited or no use under anaerobic conditions. Considering the portion of enzyme assays that are performed in the absence of oxygen, this limitation is significant.


Therefore, indicators with properties similar to indoxyl indicators without the undesirable dependence on molecular oxygen or other oxidizers would constitute a major improvement over the state of the art.


Most popular Indox indicators yield stains ranging from violet to green because red indigos are less effective for the purpose of staining.


However, it would be desirable to have available a choice of colors when using chromogenic or fluorogenic indicator systems. This is of particular importance in dual or multiple enzyme assays requiring parallel detection or in applications that require optical contrast against off white background.


Therefore, novel chromogenic enzyme indicators that expand the current color selection into the range of yellow to red would represent a further valuable addition to the art.


Moreover, common enzyme indicators are either chromogenic or fluorogenic in nature: For example, common commercial enzyme indicators based on fluorophores such as 7-hydroxycoumarines (soluble fluorogenic indicators) or quinazolines (precipitating fluorogenic indicators—see for instance: EP 0 641 351 A1) lack significant absorption in the visible electromagnetic band and thus escape detection by the human eye without the application of optical instrumentation for interrogation. In contrast, common chromogenic indicators such those derived from 3-indoxyls lack fluorescence. This is true in particular for precipitating indicators since fluorescence in the solid state is a rare phenomenon (due to the well known effect of self-quenching of excited molecules arranged in a tight lattice).


It would be advantageous over the current state of the art if enzyme indicators were made available that have both chromogenic and fluorogenic properties.


Diazonium Staining

In histology, another type of indicator is well known and often used to localize enzyme activity. This important method was pioneered by Seligman et al. (J. Histochem. Cytochem. 1954, 2, 209-229), Burstone et al. (J. Histochem. Cytochem. 1956, 4, 217-226) and Rutenburg et al. (J. Histochem. Cytochem. 1958, 6, 122-129). It is based on the reaction of stabilized diazonium salts with electron rich aromatic amines and phenols to form azo dyes. Many azo dyes are of intense color and some are fluorescent.


This diazonium coupling reaction will proceed with aromatic amines and phenols much faster than with their corresponding esters and amides. Therefore, hydrolytic enzyme activity can be detected by exposing a sample to a suitable phenolic ester or anilide followed by staining with diazonium salts. Depending on the substrate and the diazonium salts, good localization can be achieved.


In practice, different types of chromogens such as naphtylamines or naphthol derivatives are employed. There exists considerable variety of commercially available substrates of this type along with suitable diazonium staining salts.


Pearson et al. (Proc. Soc. Exptl. Biol. Med. 1961, 108, 619-613; Lab. Invest. 1963, 12, 712-720), Yarborough et al. (J. Reticuloendothelial Soc. 1967, 4, 390-408), Gossrau et al. (Histochemistry, 1987, 397-404) and others developed staining methods that are based on the reaction of Indox indicators with diazonium electrophiles for use in histology.


Mohler and Blau (Proc. Natl. Acad. Sci. USA 1996, 12423-12427) have evaluated many indicator systems for beta-D-galactosidase combining Indox indicators and various commercial diazonium salts.


It should be noted, however, that due to the carcinogenicity and high toxicity towards humans and cell cultures and the otherwise hazardous nature of diazonium salts this method poses significant danger to the user and is not compatible with either in vivo or non-destructive type of assaying in general.


In view of all the above, a superior type of indicator releasing activated signalogen which spontaneously yield signalophores in a process that is entirely independent of external factors such as molecular oxygen or any reagent or chemical species present in the surrounding environment would be desirable.


Metal Chelates

Another class of precipitating substrates are based on metal chelating molecules that form insoluble complexes with metal ions. Chelating molecules contain two or more functional groups that coordinate to a metal ion. These functional groups can be masked by labile groups to prevent the formation of a metal complex which represents a relatively common design of indicator.


Enzyme indicators based on metal chelates do have some practical relevance. For example, substrates derived from 8-hydroxyquinolines such as 8-hydroxyquinoline-beta-D-glucuronide or the naturally occurring esculetin (esculin-beta-D-glucopyranoside) can be used to detect the corresponding enzymes in the presence of iron(III) salts.


However, these indicators suffer from other drawbacks: Many of these chelating molecules display biocidal effects on culture. Such toxicity is intrinsic to any metal chelating agents since they generally interfere with the functioning of metallo-enzymes. Further, one must maintain a certain concentration of metal ions present in the assay, which may cause undesirable interference. In addition, most stains produced from metal chelation are brown and hence will not provide good contrast from background.


For example, 8-hydroxyquinoline is an excellent ligand that forms stable complexes with many transition metals. Masking the hydroxyl group with a suitable labile group produces potentially useful indicators. The assay will release 8-hydroxyquinoline as the activated signalogen which rapidly binds iron(II or III) thereby forming a precipitating metal complex that is dark colored. Moreover, 8-hydroxyquinoline possesses significant anti-microbial activity which may inhibit the growth of some prominent organisms within the format of a microbial assay. Accordingly, enzyme indicators preferably should not involve chelating agents or unnatural metal ion concentrations which by nature interfere with the course of the assay.


SUMMARY OF THE INVENTION

The present invention aims at overcoming severe limitations of current indicators including:

    • The requirement of auxiliary staining reagents such as oxygen, oxidizers, metal ions, drastic pH conditions or toxic diazonium salts.
    • The presence of toxic reagents, intermediates or products that potentially impact the assay.
    • The limitation of indicator color of precipitating chromogenic indicators to the green-blue-violet range (lacking yellow to red).
    • The lack of choice in precipitating enzyme indicators that exhibit fluorogenic properties.
    • The lack of precipitating enzyme indicators that integrate chromogenic and fluorogenic properties.


The present invention is based on the discovery that 1H-Indox-3-yl compounds and derivatives thereof efficiently undergo inter- and intramolecular aldol type reactions yielding novel types of dyes suitable for the purpose of indicating events or environmental changes.


The term “aldol condensation” is customarily used for a two step chemical reaction between an aldol donor group C1—(C═O)—C2 or its tautomer C1—C(OH)═C2 (i.e. the enol form) and an aldol acceptor C3—(C═O)—Y. The reaction involves (1) the formal addition of the former to the carbonyl group of the latter, thereby forming a carbon-carbon bond between C2 of the donor and the carbonyl carbon atom of the acceptor, and (2) the subsequent elimination of either water (H2Z, Z═O) or of HY, depending on the nature of the rest Y. Equivalent reactions wherein either one of the two carbonylic oxygens is replaced by a heteroatom containing species Z such as NH or S are termed hetero-aldol condensations. In the following, the term “aldol” processes will be intended to also include hetero-aldol processes unless specifically noted otherwise. The general principle of aldol condensations is depicted in Scheme II.




embedded image


In the above, if Y represents an effective leaving group (more likely to depart than ZH) such as halogen, cyano, thiocyano, and optionally substituted ammonium, hydroxyl, mercapto, and sulfonyl, the formation of the condensation product involves the elimination of HY (Scheme II, bottom-right structure). Otherwise, the loss of H2Z (typically water) leads to the alternative condensation product (Scheme II, bottom-left structure).


An introductory overview of intermolecular and intramolecular aldol condensation routes according to the present invention including a comparison with prior art is presented in Scheme III.




embedded image


In the above

    • Ra and Rb represent hydrogen or C1-4 alkyl,
    • R1, R2, R3, R4, R6, R7, R8, R9 and R10 are independently selected from the group consisting of hydrogen, C1-4 alkyl; C1-4 alkoxy; fused or linearly connected aryl; fused or linearly connected heteroaryl; halogen; cyano; nitro; formyl; and optionally substituted amino, carboxy, carbonyl, hydroxy and sulfonyl;
    • R5 represents either hydrogen, R11 or R12,
    • wherein R11 is




embedded image




    • and R12 is







embedded image




    • X is selected from O, NH and S, and

    • MDAB denotes 2-methoxy-4-(N,N-dimethylamino)benzaldehyde.





Hereinabove and in the following, the term “optionally substituted” stands for substitution with a general inert moiety, wherein the term “generally inert” refers herein to any moieties that do not generally interfere with the procedural practices of this invention. Representative examples of generally inert groups or moieties may generally include hydrogen and such organic groups as, for instance, aromatics to include phenyl, alkyl- and/or halogen-substituted phenyl, naphthyl, phenyl-, alkyl- and/or halogen-substituted naphthyl; saturated organic residues to include linear and branched alkyl, for example, methyl, ethyl, propyl to include cyclopropyl, butyl to include cyclobutyl and methyl-substituted cyclopropyl, pentyl to include, e.g., cyclopentyl and methyl-substituted cyclobutyl, hexyl to include, e.g., cyclohexyl, methyl-substituted cyclopentyl and dimethyl or ethyl-substituted cyclobutyl, heptyl to include cycloheptyl, etc., octyl to include cyclooctyl, etc.; halogen-substituted alkyl to include halogen-substituted cycloalkyl, e.g., fluoroalkyl, perfluoroalkyl, e.g., trifluoromethyl, and chloralkyl; alkoxy, e.g., methoxy, aromatic-oxy, e.g., phenoxy; alkylthioxy, e.g., methylthioxy; aromatic-thioxy, e.g., phenylthioxy; acyl, e.g., benzoyl and acetyl, and so forth and the like.


According to one aspect of the invention, an indicator system for detecting an external stimulus, comprises an indicator compound of the general formula




embedded image


wherein:


X is O, NH or S;

LG is a labile group with the X-LG moiety being susceptible to conversion by action of said external stimulus;


R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen, C1-4 alkyl; C1-4 alkoxy; fused or linearly connected aryl; fused or linearly connected heteroaryl; halogen; cyano; nitro; formyl; and optionally substituted amino, carboxy, carbonyl, hydroxy and sulfonyl;


R5 is either hydrogen or R12, wherein R12 is




embedded image


wherein:


Z is O, NH or S;

R6, R7, R8, R9 and R10 are independently selected from the group consisting of hydrogen, C1-4 alkyl; C1-4 alkoxy; fused or linearly connected aryl; fused or linearly connected heteroaryl; halogen; cyano; nitro; formyl; and optionally substituted amino, carboxy, carbonyl, hydroxy and sulfonyl;


and wherein, if R5 is hydrogen, the indicator system further comprises an acceptor compound of the general formula




embedded image


wherein Ra and Rb are independently selected from hydrogen and C1-4 alkyl.


According to one embodiment of the indicator system based on an intermolecular aldol reaction, R5 is hydrogen and the acceptor compound (B) is 2-methoxy-4-(N,N-dimethylamino)benzaldehyde, which has been determined preferable for the intended purpose.


Depending on the application of the indicator system, LG will be chosen from a large variety of possible labile groups, many of which are known in the art. In particular, LG is selected from the group consisting of beta-D-galactopyranoside, tert-butyldimethylsilyloxy (TBDMS), acetate, choline phosphate, alpha-D-glucopyranoside, beta-D-glucuronide sodium salt, N-acetyl-beta-D-galactopyranoside and beta-D-glucopyranoside.


According to one embodiment of the indicator system based on an intramolecular aldol reaction, R10 is selected from the group consisting of hydrogen, methyl, methoxy, phenyl, DMP or heteroaryl including, CFur, Fur, NPyr, wherein:




embedded image


According to a further aspect of the invention, a method of detecting an external stimulus in a region of interest comprises the steps of:

    • providing the region of interest with an indicator system as defined above; and
    • monitoring for a signal from a signalophore species formed as a consequence of said external stimulus;


The indicator system comprises an indicator compound having a labile group LG bound to a heteroatom X, wherein X is O, NH or S, the X-LG moiety being susceptible to conversion by action of said external stimulus, said conversion leading to formation of an active signalogen species (aS) comprising a moiety wherein X is bound to a carbon atom that is bound to a further carbon atom by a double bond; and said active signalogenic species possessing aldol donor properties thereby promoting events of aldol condensations. Therefore, said active signalogen species (aS) yield signalophore species in the presence of suitable aldol acceptor molecules, said acceptor molecules containing reactive substructures selected from the group of carbonyl, imino and thiocarbonyl.


In a preferred embodiment based on an intermolecular aldol condensation, the acceptor moiety is a carbonyl moiety and is provided by employment of an acceptor compound of the general formula




embedded image


wherein Ra, and Rb are independently selected from hydrogen and C1-4 alkyl, thereby providing an indicator system wherein the signalophore species is derived from the general structure of 2-benzylideneindoline (C) as shown below.




embedded image


In this embodiment, the acceptor compound (B) is preferably chosen as 2-methoxy-4-(N,N-dimethylamino)benzaldehyde.


In a particularly preferred embodiment based on an intramolecular aldol reaction, the acceptor moiety is a part of said indicator molecule and, if R5 is R12, the signalophore species is a 10H-indolo[1,2-a]indole with the structural formula




embedded image


wherein R13 is either OH or R10.


Note: The numbering of Rx is maintained from indicator to signalophore, but nomenclature changes. Therefore, chemical names of structures (D) are derived of the following numbering Scheme:




embedded image


In one embodiment, the method defined hereinabove is carried out under substantially oxygen-depleted conditions.


According to yet another aspect of the invention, there is provided a method of preparing an indicator compound of the general formula (A′)




embedded image


wherein:


X is O, NH or S;

LG is a labile group with the X-LG moiety being susceptible to conversion by action of said external stimulus;


R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen, C1-4 alkyl; fused or linearly connected aryl; fused or linearly connected heteroaryl; halogen; cyano; nitro; formyl; and optionally substituted amino, carboxy, carbonyl, hydroxy and sulfonyl; and R12 is




embedded image


wherein: Z is O, NH or S;


and wherein R6, R7, R8, R9 and R10 are independently selected from the group consisting of hydrogen, C1-4 alkyl; fused or linearly connected aryl; fused or linearly connected heteroaryl; halogen; cyano; nitro; formyl; and optionally substituted amino, carboxy, carbonyl, hydroxy and sulfonyl. The method comprises the step of N-arylation of an indoxyl compound of the general formula




embedded image


with a benzene derivative of the general formula




embedded image


wherein Q is a leaving group selected from iodo, bromo, triflate and tosylate, preferably iodo or bromo.


According to a further aspect of the invention, there is provided a compound of structural formula (G)




embedded image


wherein


X is O, NH or S

R1, R2, R3, R4, R6, R7, R8, R9 and R13 are independently selected from the group consisting of hydrogen, C1-4 alkyl; fused or linearly connected aryl; fused or linearly connected heteroaryl; halogen; cyano; nitro; formyl; and optionally substituted amino, carboxy, carbonyl, hydroxy and sulfonyl. These compounds (G) are generally classified as indolo[1,2-a]indoles (henceforth also denoted as “10”).


A number of compounds of formula (G) have been mentioned in Rogness and Larock (Tetrahedron Letters 2009, 50, 4003-4008), which purportedly was made available on 14 Apr. 2009. Accordingly, a preferred embodiment encompasses the above defined compounds of structural formula (G) with the exception of the compounds listed in Tables 2 and 3 of Rogness and Larock (see claim 14).


According to a further aspect of the invention, a compound of structural formula (G) is used in an indicator system for detecting an external stimulus. Such external stimuli include but are not limited to: Heating or temperature variations; electromagnetic irradiation; applied electric potentials; particular chemical environments such as acidic, alkaline, oxidizing or reducing; presence of particular chemical species such as ions, enzymes, oxygen or oxidizing agents, hydrogen or reducing agents; presence of particular biological species such as viruses, bacteria, fungi, antibodies, cells and cellular organelles, cellular tissue; and even plants, animals and humans as well as organs, bodily fluids, waste or decay thereof.


The indicators or indication systems according to the invention are particularly useful for the purpose of staining cells, microbial colonies or cell tissue.


According to one embodiment, staining or indication with the IO indicators of this invention is used in combination with classic Indox staining or indication.


The manifold uses of IO indicators include but are not limited to staining of bacterial colonies growing in blood cultures, staining of fungal cultures, staining for labelling of individual cells, microbial colonies or cell tissue, staining for the purpose of inducing fluorescence within cellular tissue, colonies of cells, cells, cellular structures or organelles.


Moreover, IO staining is useful for the purpose of imaging static conditions such as size, location, enumeration and spread of benign or malignant cellular tissue, cells, cellular structures, cell walls, membranes, compartments, organelles, antibodies, chromosomes, genomes, genes, plasmids, vectors, nucleic acid strands, proteins or enzymes.


Furthermore, IO staining is useful for the purpose of visualizing dynamic events such as diffusion, growth or decay of benign or malignant cellular tissue, individual cells, cellular structures, organelles, antibodies, chromosomes, genomes, genes, plasmids, vectors, nucleic acid strands, proteins or enzymes, and processes of phagocytosis and pathogenesis.


Still further, IO staining is useful for the purpose of recording, retrieving, storing or archiving digital information.





DETAILED DESCRIPTION OF THE INVENTION

The above mentioned and other features and objects of this invention and the manner of achieving them will become more apparent and this invention itself will be better understood by reference to the following description of various embodiments of this invention taken in conjunction with the accompanying drawings, wherein:



FIG. 1 shows UV/visible absorption spectra (in arbitrary absorbance units “AU”) of various 10H-indolo[1,2-a]indole stains (labelled “IOx”) and of the corresponding beta-D-galactosidase indicators (labelled “Ixa”) (see Tables Ia and Ic for symbol definitions): a) x=14; b) x=16; c) x=19; d) x=21; e) x=17; f) x=15;



FIG. 2 shows fluorescence emission spectra in relative fluorescence units (RFU) for excitation at 360 nm of bacterial colonies stained with various 10H-indolo[1,2-a]indoles (see Table Ia for symbol definitions); and



FIG. 3 shows fluorescence excitation spectra in relative fluorescence units (RFU) for emission at 550 nm of bacterial colonies stained with various 10H-indolo[1,2-a]indoles (see Table Ia for symbol definitions).





INTERMOLECULAR ALDOL INDICATORS
MDAB Staining and BI Indicator Systems

In this first section a novel method termed MDAB aldol staining is disclosed. The method is based on the discovery that certain 1H-Indox-3-yl activated signalogens and 2-methoxy-4-(N,N-dimethylamino)benzaldehyde (MDAB) auxiliary reagent efficiently undergo an intermolecular aldol condensation to yield dark red to brown colored precipitates suitable for the purpose of indication, thereby providing a novel indicator system significantly expanding upon the current art.


The basis of the MDAB staining technique disclosed here is the discovery that Indox activated signalogens possess significant aldol donor properties and that such properties are highly specific towards certain aldol acceptors, in particular MDAB.


Specifically, it was discovered that widely used commercial Indox Indicators releasing Indoxol activated signalogen 5-bromo-4-chloro-1H-indol-3-ol (Table Ib, aS4) and 5-bromo-6-chloro-1H-indol-3-ol (Table Ib, aS5) produce dark violet stains derived of the 2-benzylideneindolin-2-one parent structure (Table Ic, entries 11-22).


Further, it was recognized that said aldol donor properties of Indox activated signalogens can be moderated or eliminated by masking the X—H moiety in position 3 by replacing the hydrogen with a labile group.


In principle, Indox indicators currently used in indicator systems including oxygen or other oxidizers as auxiliary reagents can be used with MDAB as the auxiliary reagent instead.


However, in practice, not all Indox activated signalogens (or the indicators derived thereof) form efficient aldol donor/acceptor pairs with MDAB: For instance the commonly used 5-bromo-4-chloro-1H-indol-3-ol (Table Ib, aS4) and 5-bromo-6-chloro-1H-indol-3-ol (Table Ib, aS5) activated signalogens proved far more effective than 6-chloro-1H-indol-3-ol (Table Ib, aS3).


For example, O-silylated 5-bromo-4-chloro-1H-indol-3-ol (Table Ia, I4b) was used as a simple indicator for fluoride ions (external stimulus): The silyl group is labile towards fluoride ions in the presence of which the 5-bromo-4-chloro-1H-indol-3-ol (aS4) is set free to react with MDAB to yield mentioned insoluble pink precipitate (Table Ic, BI4).


In a second example, a blend of the commercial reagent 5-bromo-4-chloro-1H-indol-3-yl-beta-D-galactopyranoside (Table Ia, I4a) and MDAB yielded said pink dye upon incubation with beta-D-galactosidase in the absence of oxygen while it is well known in the art that I4a by itself depends on the presence of oxygen or an oxidizer for functioning as an indicator.


Further, Indox activated signalogens 3-aminoindole or 3-mercaptoindole (Table Ib, aS6 and aS7) were tested for their aldol donor properties. While 3-aminoindole failed to yield any aldol product with MDAB (Table Ic, BI6), 3-mercaptoindole and MDAB did produce the characteristic pink dye (BI7) under strongly acidic conditions (Tables IIa-c, entries 14 and 15).


Indox indicator systems tested are listed in Tables IIa (aerobic, no MDAB), IIb (aerobic, MDAB) and IIc (anaerobic, MDAB).


Further elaboration revealed that Indox/MDAB indication can be used to stain microbial colonies by using characteristic biomarker enzymes as external stimulus. Importantly, MDAB showed no toxic effect on microbial cell growth in these studies. Results are summarized in Table III.


For example, microbial plating media containing the I4a/MDAB indicator system were incubated in the presence and absence of atmospheric oxygen: While at atmospheric concentration of oxygen the formation of turquoise indigo (Table Ic, IN4) dominated, stained colonies appeared pink due to the formation of BI4 (Table Ic) under micro-anaerobic or anaerobic conditions due to the effect of MDAB staining (Table III, entry 10).


In general, commercially available Indox indicators derived of aS4 or aS5 in combination with 2 to 4 equivalents of MDAB were found to be the preferable indicator systems for staining of microbial cultures under anaerobic conditions. Indicators I9a, I10a, I11a, and I12a in combination with MDAB represent indicator systems that are effective under aerobic conditions (Table III, entries 26-37): It appears that the formation of indigo from N-arylated Indox activated signalogens is inefficient and that the intramolecular aldol condensation dominates instead.


Intramolecular Aldol Indicators: IO Indicator Systems

The MDAB staining disclosed above is based on the unique match of an aldol donor and a MDAB aldol acceptor pair. In the following, it is disclosed that a similar effect can be achieved by chemically linking aldol donor and acceptor.


It is well known in the art that intramolecular ring-closure reactions including intramolecular aldol reactions proceed at high rates especially if 5- or 6-membered rings are formed in the process. Therefore, the concept was developed to connect aldol donor and acceptor such that the spatial arrangement of donor and acceptor moieties would favor the event of an intramolecular aldol condensation.


In analogy to the above described MDAB staining, untimely occurrence of the aldol condensation can be prevented by the masking effect of a labile group conjugated to the aldol donor. A spontaneous aldol condensation takes place after departure or modification (e.g. chemical reduction) of the labile group in response to an external stimulus.


The design of an intramolecular aldol indicator requires the aldol acceptor to be attached to the donor by means of a chemical structure linking the C3 atom of the aldol acceptor (Scheme II). Traditional IN Indox indicators provide a perfect anchor site for the linker: The indole nitrogen. Said linking may include one or two sequentially arranged atoms C1 and C2 as shown in Scheme IV. In the former case a formal intramolecular aldol condensation would yield a 5-membered ring whereas in the latter case it would yield a 6-membered ring in the signalophore structure.




embedded image




    • C1, C2, C3 represent carbon atoms optionally substituted by hydrogen; C1-4 alkyl; fused or linearly connected aryl; fused or linearly connected heteroaryl; halogen; cyano; thio-cyano; nitro; nitroso; formyl; and optionally substituted amino, carboxy, carbonyl, hydroxyl, mercapto and sulfonyl

    • R1, R2, R3, R4 are selected from the group consisting of hydrogen, C1-4 alkyl; fused or linearly connected aryl; fused or linearly connected heteroaryl; halogen; cyano; thiocyano; nitro; nitroso; formyl; and optionally substituted amino, carboxy, carbonyl, hydroxyl, mercapto and sulfonyl

    • X is selected from O, NH and S.





The aldol acceptor is preferably chosen as an aromatic carbonyl compound, (hence C1 and C2 represent members of an aromatic ring) such that an intramolecular aldol condensation would result in the formation of an extended conjugated system thereby providing the signalophore with desirable optical properties.


Due to the kinetic advantage of an intramolecular aldol reaction donor and acceptor molecules do not need to form a matching donor/acceptor pair such as Indox/MDAB.


Of the many synthetic routes explored to achieve the desired linking between donor and acceptor structures, N-arylation was discovered to be the preferred method.


N-arylation is a well established synthetic method. For example it is well known in the art that indoles readily react with iodobenzene to produce N-phenylindoles in high yields.


For instance 3-indolyl-beta-D-galactoside (I1a) was reacted with derivatives of Iodobenzene in DMF in the presence of a copper catalyst to yield the corresponding 1-phenyl-3-indolyl-beta-D-galactopyranoside (I8a). This is remarkable since the labile group was chosen to be a carbohydrate and said carbohydrate was used without chemical protection.


In analogy, novel aldol type indicators were obtained in one simple step and in high yields by N-arylation of the corresponding commercially 1H-indox-3-yl indicators under a variety of conditions including traditional Ullmann type copper catalysis or newer variants thereof such as recently published by Taillefer et al. (Efficient Iron/Copper Co-Catalyzed Arylation of Nitrogen Nucleophiles. Angew. Chem., Int. Ed. 2007, 46, 934-936).




embedded image




    • R1, R2, R3, R4, R6, R7, R8, R9 and R10 are selected from the group consisting of hydrogen, C1-4 alkyl; fused or linearly connected aryl; fused or linearly connected heteroaryl; halogen; cyano; nitro; formyl and optionally substituted amino, carboxy, carbonyl, hydroxy and sulfonyl

    • X is selected from O, NH and S.





The concept was demonstrated to be of general validity: A significant number of commercial Indox indicators were successfully conjugated to a range of aromatic aldol acceptors by means of the above mentioned N-arylation techniques thereby providing simple, efficient and generic entry into a novel family of indicators (Table Ia, entries 15-46).


Novel indicators generally did respond to suitable external stimuli as anticipated (Tables IVa-c). Removal of the labile masking group triggered the postulated aldol condensation.


Ketones, (acting as internal acceptors), generally yielded brightly colored insoluble dyes with colors ranging from yellow, orange, red to brown. Occasionally, intense green fluorescence of transient nature was observed which is characteristic of 3-indoxyl species such as are represented by the aS species, which in the postulated process of aldol condensation would be of transient nature as well.


Esters (acting as internal acceptors), in contrast, produced persistently green fluorescent dyes (Table Ic: IO10, IO11, IO12) freely soluble in water above pH 5.


Upon further acidification said dyes formed orange colored non-fluorescent precipitates from aqueous solutions. This process was found to be completely reversed by the addition of base. Evidently, said dyes are highly acidic in nature and highly fluorescent in deprotonated form.


Generally, all of these dyes are derived of a parent indolo[1,2-a]indole (Table Ic, entries 23-46). The indolo[1,2-a]indole structure formally consists of two indoles sharing the nitrogen and the adjacent pyrrole carbon. Despite the appeal and simplicity of this structure, indolo[1,2-a]indoles (henceforth denoted “10”) appear to be novel.


In FIG. 1 absorption spectra of various IO stains are overlaid with the ones of the corresponding indicators. The graphs illustrate that IO absorption between 300 and 400 nm and 400 and 500 nm are both lacking in the corresponding indicators and therefore provides useful detectable signal.


For example incubation of the N-benzophenone conjugate of 6-chloroindoxyl-beta-D-galactoside (121a) with beta-D-galactosidase for 24 h produced a bright yellow precipitate which was collected, washed with water, dried and characterized as 7-chloro-11-phenyl-10H-indolo[1,2-a]indol-10-one (Table Ic, IO21), which corresponds to the expected aldol condensation product.


IO staining was tested on plating media inoculated with various bacterial beta-D-galactosidase positive strains. Colonies of beta-D-galactosidase positive strains of E. coli appeared yellow to red depending on the indicator used while beta-galactosidase negative Salmonella colonies appeared no different in the presence or absence of tested galactosidase indicators (Tables IVa and IVb).


Further, IO staining was tested on different bacteria producing a variety of different biomarker enzymes (Table IVc).


It should be noted that IO staining and classical indigo (IN) staining can be usefully combined, thereby extending the color scheme (Table IVd): For instance indicator I4h was used in combination with I21a in a dual plating media assay staining beta-D-glucosidase and beta-D-galactosidase bacterial species concurrently. While the strains positive for the former biomarker stained blue and strains positive for the latter stained yellow, strains positive for both enzymes stained green (mixture of blue and yellow).


It is well known that colonial growth of facultative anaerobic microbial species is relatively slow under anaerobic conditions. Due to the prolonged time of incubation, indicator systems used for the purpose to stain anaerobically cultured colonies must provide excellent localization (or minimal diffusion). From the experimental data shown in Table IVe it can be concluded that some IO indicator systems are excellently suited for said purpose. At the same time the data illustrate the failure of classic IN staining (I4a) and demonstrate that accumulation of corresponding activated signalogen caused by the absence of matching auxiliary reagent (e.g. oxygen) partially inhibits microbial growth.


Blood cultures represent a common and essential tool in clinical microbiology. Staining of microbial colonies on agar plates is obscured by the dark color and lack of translucency of Blood Agar plates. Therefore, IO indicator systems have been evaluated for use on Blood Agars (Table IVf). The experiments produced very favorable results: 10 signalophores provided excellent optical contrast and localization.


Staining of fungal cultures is another important area of application for biological indicator systems. For this purpose, an IO indicator system has been devised which is labile towards the action of D-galactosamidase, a biomarker enzyme for the notorious pathogen Candida albicans. Although colonial growth under the culturing conditions chosen was modest, in the presence of I21g fungal colonies producing a matching external stimulus turned bright yellow and became readily distinguishable by the human eye (Table IVg).


All of the plating media listed in Tables IVa-f were inspected under illumination at 366 nm before, during and after incubation. Thereby it was discovered that 10H-indolo[1,2-a]indol-10-ones are fluorescent in the solid state and that the effect of fluorescence was maintained by IO stained colonies: Generally, at 366 nm plating media (except for Blood Agar plates) containing IO indicator systems provide a bluish background on which unstained colonies appear as faint shadows, whereas IO stained colonies stand out in bright colors ranging from yellow-green to red-brown providing excellent visual contrast and high sensitivity.


The blood ingredients of Blood Agar plates effectively quench fluorescence. Therefore, plates appear black under 366 nm UV light. Interestingly, fluorescence of IO stains dispersed in colonies growing on Blood Agar plates remains undisturbed and provides spectacular illumination of colonies against the black background (Table IVf).


In the following, the discovery that IO stains induced persistent fluorescence within microbial colonies was further elaborated: Fluorescence could be quantified in colonies harvested from plating media by using a standard plate reader. Intensity and wavelength of the emission was strongly dependent on the type of indicator system used. Data collected in various emission scans are presented in FIG. 2.


The corresponding samples were also subjected to excitation scans recording emission at 550 nm (FIG. 3). Interestingly, IO stains were found to be excitable between 300 and 500 nm, which is an unusually broad range. Clearly, the bright shining colors of many IO stains are due to the effect of excitation (optical brightening) by ambient light.


In an extension of the above, it was also recognized that standard liquid culturing of E. coli in the presence of IO indicator systems yielding fluorescent signalophores provides a novel method for fluorescence labeling of individual cells: In samples taken from said culture, individual cells of E. coli became clearly visible under a standard fluorescence microscope.


IO staining, therefore, may provide a simple and economic method for live cell labeling, which commonly relies on the elaborate application of fluorescent antibodies or genetic vectors that encode fluorescent proteins.


Finally, the scope of the invention was further explored by evaluation of structural variations of IO indicator systems which are derived of the nitrogen and sulfur analogues of 1-aryl-1H-indol-3-ol activated signalogen.




embedded image


For said purpose, 1-(2-benzoylphenyl)-1H-indol-3-yl ethyl carbamate (I32) was subjected to alkaline and pig liver esterase catalyzed hydrolysis. A yellow precipitate was isolated, which, by means of comparison with a reference sample, was identified as 11-phenyl-10H-indolo[1,2-a]indol-10-one (I019) rather than the expected 11-phenyl-10H-indolo[1,2-a]indol-10-imine (I032). A plausible explanation is provided by the possible hydrolysis of the imino group under the conditions of assay which would transform IO32 to the observed IO19. Independent of the mechanism of action and its practical relevance, the experiment demonstrates that in principle the concept can be extended to include indicator systems where the labile group is attached to a nitrogen atom. The relevance of this finding lies in a manifold of important biological applications which base on the detection of amino-peptidase activity and the fact that no useful precipitating indicator systems are available in the current state of the art.


In a second example, the oxidized form of 1-(2-acetylphenyl)-1H-indol-3-thiole (aS33), bis[1-(2-acetylphenyl)-1H-indol-3-yl]-disulfane (I33) was subjected to reduction of the S—S bridge by TCEP, a standard reagent used in protein biochemistry, thereby releasing aS33. While no detectable signal was observed at neutral conditions, the assay solution turned to yellow, thereby clearly indicating the event of disulfide reduction, when alkaline conditions where used. This example underlines the fact that IO indicator systems represent a generic and highly versatile concept. It also serves to emphasize that the IO indicator systems are by no means limited to detect external stimuli associated with enzymatic activity. The many examples presented herein below are not to be taken as a limitation of this invention but merely reflect the practical field the inventors are engaged in.


EXAMPLES
Example 1
Preparation of indicators I8 to I31 by N-arylation of I1 to I4 (Table Ia)

Note: Aromatic iodo compounds were either commercially available or prepared by standard Friedel-Crafts acylation with ortho-iodobenzoic acid. 2-(2-Iodobenzoyl)-N-methylpyrrole was prepared in analogy to Carson et al. (WO2000048584), 2-(2-iodobenzoyl)furan and 2-(2-iodobenzoyl)-5-carboxyfuran in analogy to Garland et al. (DE2557956) and 4-chloro-2-iodobenzophenone according to Gabbutt et al. (Tetrahedron 2006, 62, 737-745). 1-Acetyl-2-iodo-4-methoxybenzene and 1-benzoyl-2-iodo-4-methoxybenzene were obtained by Friedel-Crafts reaction of 3-iodoanisol in the presence of aluminium chloride.


Experiments were carried out in a Synthos 3000 multimode microwave reactor from Anton Paar GmbH. The following parameters were adjusted: P(max)=1400 W; T(IRmax)=200° C.; Drive: rotation; Stirrer: 3; p-rate=2.0 bar/s. Ramp-time=2 min (130° C.) and hold-time=180 min (130° C.). A PTFE-liner (100 ml) fitted with a Teflon-coated stirring bar was used as the reaction vessel. In a typical procedure a mixture of 5 mMol of 1H-Indol-3-yl indicator, 10 mMol of the corresponding aryl iodide, 5 mMol potassium carbonate, 0.5 mMol copper(I) iodide in 20 ml of DMF was subjected to MW irradiation. The product mixture was filtered and the solids washed with 10 ml ethanol. The filtrate was evaporated to dryness and the crude product purified by flash chromatography [e.g. silica gel, toluene/ethanol (5:1)].


IR spectra were recorded as neat solids on a Perkin-Elmer FT-IR spectrophotometer, model Spectrum ONE (v [cm−1]). 1H- and 13C-NMR spectra were recorded at 298 K on Brucker AVANCE-400 [400.13 MHz (1H), 100.61 MHz (13C)] spectrometer (δ [ppm], J [Hz]).


1-Phenyl-1H-indol-3-yl-beta-D-galactopyranoside (I8a)

Yield: 628 mg (34%); TLC [toluene/ethanol (5:3)]: Rf 0.47.



1H-NMR [DMSO-d6]: 7.73-7.71 (m, 1H); 7.56-7.54 (m, 5H); 7.42 (s, 1H); 7.37-7.32 (m, 1H); 7.23-7.19 (m, 1H); 7.14-7.10 (m, 1H); 5.30-5.28 (d, 1H); 4.89-4.87 (d, 1H); 4.74-4.72 (d, 1H, J=7.8 Hz); 4.71-4.69 (d, 1H); 4.54-4.53 (d, 1H); 3.72-3.66 (m, 1H); 3.61-3.56 (m, 3H); 3.48-3.41 (m, 2H).



13C-NMR [DMSO-d6]: 139.18, 139.01, 132.28, 129.73, 125.73, 123.33, 122.99, 121.42, 119.60, 118.19, 113.35, 110.17, 104.22, 75.71, 73.33, 70.39, 68.23, 60.54.


6-Chloro-1-phenyl-1H-indol-3-yl-beta-D-galactopyranoside (I9a)

Yield: 560 mg (28%); TLC [toluene/ethanol (5:3)]: Rf 0.43.



1H-NMR [DMSO-d6]: 7.72-7.70 (m, 1H); 7.58-7.56 (m, 4H); 7.52-7.51 (m, 1H); 7.45 (s, 1H); 7.41-7.37 (m, 1H); 7.16-7.13 (m, 1H); 5.30-5.29 (d, 1H); 4.89-4.87 (d, 1H); 4.72-4.71 (d, J=7.8 Hz, 1H); 4.69-4.67 (m, 1H); 4.54-4.53 (d, 1H); 3.71-3.63 (m, 2H); 3.59-3.55 (m, 3H); 3.43-3.39 (m, 1H).



13C-NMR [DMSO-d6]: 138.75, 138.55, 132.48, 129.85, 127.82, 126.29, 123.56, 120.11, 119.99, 119.65, 114.43, 109.81, 104.18, 75.73, 73.23, 70.30, 68.18, 60.50.


1-[2-(Methoxycarbonyl)phenyl]-1H-indol-3-yl-beta-D-galactopyranoside (I10a)

Yield: 496 mg (23%); TLC [toluene/ethanol (5:3)]: Rf 0.41.



1H-NMR [DMSO-d6]: 7.89-7.87 (m, 1H); 7.77-7.69 (m, 2H); 7.56-7.52 (m, 2H); 7.25-7.02 (m, 4H); 5.27-5.26 (br. d, 1H); 4.87 (br. s, 1H); 4.67-4.65 (d, J=7.8 Hz, 1H); 4.65-4.64 (br. d, 1H); 4.53-4.52 (br. d, 1H); 3.71-3.63 (m, 2H); 3.58-3.49 (m, 3H); 3.44-3.39 (m, 1H).



13C-NMR [DMSO-d6]: 166.38, 138.94, 137.68, 133.77, 133.16, 130.73, 128.21, 128.04, 127.41, 122.79, 120.96, 119.41, 118.16, 114.62, 109.39, 104.54, 75.65, 73.34, 70.50, 68.16, 60.43, 52.24.


6-Chloro-1-[2-(methoxycarbonyl)phenyl]-1H-indol-3-yl-beta-D-galactopyranoside (I11a)

Yield: 526 mg (23%); TLC [toluene/ethanol (5:3)]: Rf 0.41.



1H-NMR [DMSO-d6]: 7.91-7.89 (m, 1H); 7.78-7.74 (m, 1H); 7.70-7.68 (m, 1H); 7.60-7.55 (m, 2H); 7.19 (s, 1H); 7.10-7.08 (m, 1H); 6.98 (d, 1H); 4.65-4.63 (d, J=7.8 Hz, 1H); 3.66-3.61 (m, 2H); 3.56-3.51 (m, 3H); 3.48 (s, 3H); 3.42-3.39 (m, 1H).



13C-NMR [DMSO-d6]: 165.94, 138.58, 136.99, 134.01, 133.29, 130.77, 128.25, 128.14, 127.94, 127.52, 119.68, 119.62, 119.58, 115.73, 109.12, 104.46, 75.64, 73.19, 70.35, 68.05, 60.34, 52.23.


5-Bromo-4-chloro-1-[2-(methoxycarbonyl)phenyl]-1H-indol-3-yl-beta-D-galactopyranoside (I12a)

Yield: 572 mg (21%); TLC [toluene/ethanol (5:3)]: Rf 0.41.



1H-NMR [DMSO-d6]: 7.93-7.91 (m, 1H); 7.81-7.74 (m, 1H); 7.62-7.58 (m, 1H); 7.54-7.52 (m, 1H); 7.37-7.34 (m, 1H); 7.27 (s, 1H); 6.87-6.84 (m, 1H); 4.70-4.68 (d, J=7.8 Hz, 1H); 3.70-3.63 (m, 2H); 3.54-3.52 (m, 3H); 3.49 (s, 3H); 3.43-3.39 (m, 1H).



13C-NMR [DMSO-d6]: 165.56, 139.53, 137.85, 136.76, 133.66, 133.40, 130.88, 128.63, 128.38, 128.20, 126.60, 123.67, 116.21, 112.73, 110.12, 103.91, 75.59, 73.46, 70.31, 68.05, 60.30, 52.33.


1-(2-Formylphenyl)-1H-indol-3-yl-beta-D-galactopyranoside (I13a)

Yield: 443 mg (22%); TLC [toluene/ethanol (5:3)]: Rf 0.42.



1H-NMR [DMSO-d6]: 9.64 (s, CHO); 8.01-7.99 (m, 1H); 7.89-7.85 (m, 1H); 7.75-7.73 (m, 1H); 7.66-7.59 (m, 2H); 7.45 (s, 1H); 7.26-7.09 (m, 3H); 5.29-5.27 (br. d, 1H); 4.89-4.88 (br. d, 1H); 4.75-4.73 (d, J=7.8 Hz, 1H); 4.63-4.61 (br. d, 1H); 4.54-4.53 (br. d, 1H); 3.71-3.65 (m, 2H); 3.54 (br. s, 3H); 3.43-3.36 (m, 1H).



13C-NMR [DMSO-d6]: 189.40, 141.07, 139.27, 135.46, 135.02, 131.03, 128.37, 127.99, 127.91, 123.37, 120.92, 119.88, 118.24, 115.60, 109.66, 104.13, 75.61, 73.26, 70.36, 68.09, 60.35.


1-(2-Acetylphenyl)-1H-indol-3-yl-beta-D-galactopyranoside (I14a)

Yield: 1.20 g (60%); TLC [toluene/ethanol (5:3)]: Rf 0.38.



1H-NMR [DMSO-d6]: 7.75-7.70 (m, 3H); 7.59-7.54 (m, 2H); 7.21 (s, 1H); 7.18-7.09 (m, 2H); 7.05-7.03 (m, 1H); 5.29-5.27 (br. d, 1H); 4.87-4.85 (br. d, 1H); 4.69-4.67 (d, J=7.8 Hz, 1H); 4.63-4.61 (br. s, 1H); 4.52-4.51 (br. d, 1H); 3.71-3.62 (m, 2H); 3.58-3.50 (m, 3H); 3.46-3.39 (m, 1H); 1.82 (s, 3H).



13C-NMR [DMSO-d6]: 200.12, 139.13, 137.09, 136.59, 133.75, 132.61, 129.14, 127.86, 127.69, 123.10, 120.72, 119.64, 118.16, 114.58, 109.56, 104.24, 75.56, 73.23, 70.38, 68.05, 60.28, 28.28.


1-(2-Acetylphenyl)-4-chloro-1H-indol-3-yl-beta-D-galactopyranoside (I15a)

Yield: 1.09 g (49%); TLC [toluene/ethanol (5:3)]: Rf 0.41.



1H-NMR [DMSO-d6]: 7.79-7.72 (m, 2H); 7.62-7.58 (m, 1H); 7.54-7.53 (m, 1H); 7.29 (s, 1H); 7.12-7.07 (m, 2H); 6.97-6.92 (m, 1H); 5.02-5.01 (br. d, 1H); 4.86-4.85 (br. d, 1H); 4.77-4.75 (d, J=7.8 Hz, 1H); 4.63 (br. s, 1H); 4.55-4.54 (br. d, 1H); 3.72-3.65 (m, 2H); 3.55 (br. s, 3H); 3.46-3.40 (m, 1H); 1.92 (s, 3H).



13C-NMR [DMSO-d6]: 199.75, 138.48, 137.14, 136.00, 135.01, 132.72, 129.27, 128.24, 128.07, 124.21, 123.63, 120.41, 117.24, 114.95, 108.65, 103.51, 75.53, 73.54, 70.39, 68.07, 60.27, 28.40.


1-(2-Acetylphenyl)-6-chloro-1H-indol-3-yl-beta-D-galactopyranoside (I16a)

Yield: 0.96 g (44%); TLC [toluene/ethanol (5:3)]: Rf 0.46.



1H-NMR [DMSO-d6]: 7.78-7.70 (m, 3H); 7.62-7.57 (m, 2H); 7.25 (s, 1H); 7.17-7.12 (m, 1H); 7.05-7.04 (m, 1H); 5.30-5.29 (br. d, 1H); 4.88-4.86 (br. d, 1H); 4.68-4.66 (d, J=7.7 Hz. 1H); 4.63-4.61 (br. s, 1H); 4.52-4.51 (br. d, 1H); 3.70-3.62 (m, 2H); 3.56-3.50 (m, 3H); 3.42-3.39 (m, 1H); 1.91 (s, 3H).



13C-NMR [DMSO-d6]: 199.95, 138.83, 137.06, 135.83, 133.97, 132.71, 129.29, 128.18, 127.85, 125.23, 120.04, 119.70, 119.49, 115.73, 109.38, 104.25, 75.62, 73.17, 70.33, 68.04, 60.29, 28.45.


1-(2-Acetylphenyl)-5-bromo-4-chloro-1H-indol-3-yl-beta-D-galactopyranoside (I17a)

Yield: 0.61 g (23%); TLC [toluene/ethanol (5:3)]: Rf 0.42.



1H-NMR [DMSO-d6]: 7.83-7.80 (m, 1H); 7.77-7.73 (m, 1H); 7.64-7.60 (m, 1H); 7.56-7.53 (m, 1H); 7.41-7.39 (m, 1H); 7.35 (s, 1H); 6.92-6.90 (m, 1H); 5.07-5.06 (br. d, 1H); 4.87-4.86 (br. d, 1H); 4.74-4.72 (d, J=7.7 Hz, 1H); 4.62 (br. s, 1H); 4.55-4.53 (br. d, 1H); 3.71-3.64 (m, 1H); 3.55 (br. s, 3H); 3.47-3.39 (m, 2H).



13C-NMR [DMSO-d6]: 199.56, 138.04, 137.03, 135.44, 133.60, 132.77, 129.38, 128.54, 128.33, 126.96, 123.77, 118.55, 116.27, 113.05, 110.39, 103.72, 75.57, 73.44, 70.32, 68.06, 60.27, 28.50.


1-(2-Acetyl-5-methoxyphenyl)-6-chloro-1H-indol-3-yl-beta-D-galactopyranoside (I18a)

Yield: 1.6 g (65%); TLC [toluene/ethanol (4:1)]: Rf 0.36.


FT-IR: 3459m, 2964w, 2927w, 2867w, 1665s, 1601s, 1569m, 1497m, 1471s, 1451s, 1372s, 1267s, 1220s, 1140s, 1081s, 1053s, 1020s, 975m, 945m, 880m, 800m, 735m, 696m.



1H-NMR [DMSO-d6]: 7.80 (d, J=8.7, 1 arom. H); 7.71 (d, J=8.5, 1 arom. H); 7.28 (s, 1 arom. H); 7.17-7.11 (m, 2 arom. H); 7.07 (d, J=2.5, 1 arom. H); 7.06 (d, J=1.7, 1 arom. H); 5.30 (d, J=5.0, OH); 4.87 (d, J=5.8, OH); 4.68 (d, J=7.8, H—C(1)Gal); 4.64 (t, J=5.2, OH); 4.52 (d, J=4.7, OH); 3.88 (s, OCH3); 3.70 (t, J=4.0, H—C(4)Gal); 3.65 (mc, 1H—CGal); 3.58-3.51 (m, 3H—CGal); 3.48-3.39 (m, 1H—CGal); 1.86 (s, CH3).



13C-NMR [DMSO-d6]: 197.86 (s, C═O); 162.54 (s, C—OCH3); 138.79, 138.18, 134.01 (3 s); 131.68 (d); 129.00 (s); 128.82, 128.12 (2 d); 127.85 (s); 125.23, 120.01, 119.66 (3 d); 119.53 (s); 115.67, 113.92, 113.27, 109.44 (4 d); 104.22 (d, C(1)Gal); 75.68, 73.22, 70.36, 68.11 (4 d, C(2-5)Gal); 60.38 (t, C(6)Gal); 55.90 (q, OCH3); 28.03 (q, CH3—C═O).


1-(2-Benzoylphenyl)-1H-indol-3-yl-beta-D-galactopyranoside (I19a)

Yield: 1.09 g (46%); TLC [toluene/ethanol (5:3)]: Rf 0.41.



1H-NMR [DMSO-d6]: 7.82-7.81 (m, 1H); 7.80-7.79 (m, 1H); 7.78-7.77 (m, 2H); 7.70-7.69 (m, 1H); 7.68-7.67 (m, 3H); 7.64-7.13 (m, 4H); 7.03 (s, 1H); 6.99-6.95 (m, 1H); 5.23-5.22 (br. d, 1H); 4.85-4.83 (br. d, 1H); 4.68-4.65 (br. s, 1H); 4.51-4.50 (br. d, 1H); 4.29-4.27 (d, J=7.7 Hz, 1H); 3.72-3.70 (m, 1H); 3.63-3.52 (m, 3H); 3.42-3.32 (m, 2H).



13C-NMR [DMSO-d6]: 195.54, 138.83, 136.97, 135.68, 135.48, 133.41, 132.92, 132.21, 129.92, 128.30, 128.14, 127.86, 127.48, 127.18, 125.24, 122.63, 120.61, 119.38, 117.80, 115.27, 109.87, 104.49, 75.40, 73.19, 70.31, 67.91, 60.17.


1-(2-Benzoylphenyl)-4-chloro-1H-indol-3-yl-beta-D-galactopyranoside (I20a)

Yield: 0.87 g (34%); TLC [toluene/ethanol (5:3)]: Rf 0.52.



1H-NMR [DMSO-d6]: 7.82-7.78 (m, 1H); 7.70-7.60 (m, 3H); 7.45-7.41 (m, 3H); 7.26-7.22 (m, 2H); 7.10 (s, 1H); 7.05-6.94 (m, 3H); 4.89-4.87 (d, 1H); 4.83-4.81 (d, 1H); 4.66-4.64 (br. s, 1H); 4.53-4.52 (d, J=4.7 Hz, 1H); 4.43-4.41 (br. s, 1H); 3.72-3.70 (m, 1H); 3.61-3.51 (m, 3H); 3.48-3.41 (m, 2H).



13C-NMR [DMSO-d6]: 195.25, 138.20, 136.41, 135.87, 135.58, 134.70, 133.14, 132.23, 129.84, 128.48, 128.02, 127.62, 123.76, 123.15, 120.19, 117.01, 115.40, 108.94, 103.68, 75.36, 73.46, 70.26, 67.91, 60.10.


1-(2-Benzoylphenyl)-6-chloro-1H-indol-3-yl-beta-D-galactopyranoside (I21a)

Yield: 1.30 g (51%); TLC [toluene/ethanol (5:3)]: Rf 0.21.



1H-NMR [DMSO-d6]: 7.83-7.79 (m, 1H); 7.71-7.64 (m, 3H); 7.48-7.46 (m, 1H); 7.41-7.37 (m, 3H); 7.26-7.13 (m, 3H); 7.07 (s, 1H); 7.01-6.98 (m, 1H); 5.24-5.23 (br. d, 1H); 4.86-4.84 (br. d, 1H); 4.68-4.65 (br. s, 1H); 4.52-4.50 (br. d, 1H); 4.29-4.27 (d, J=7.5 Hz, 1H); 3.71-3.69 (m, 1H); 3.59-3.53 (m, 3H); 3.44-3.33 (m, 2H).



13C-NMR [DMSO-d6]: 195.45, 138.60, 136.32, 135.66, 135.63, 133.66, 133.04, 132.35, 129.93, 128.82, 128.41, 128.12, 127.96, 127.49, 127.34, 125.23, 119.78, 119.35, 119.28, 116.30, 109.69, 104.49, 75.46, 73.13, 70.26, 67.91, 60.18.


1-(2-Benzoylphenyl)-6-chloro-1H-indol-3-yl-alpha-D-glucopyranoside (I21e)

Yield: 1.57 g (61%); TLC [toluene/ethanol (5:3)]: Rf 0.28.



1H-NMR [DMSO-d6]: 7.83-7.79 (m, 1H); 7.72-7.62 (m, 3H); 7.46-7.44 (m, 1H); 7.39 (s, 1H); 7.38-7.35 (m, 2H); 7.21-7.17 (m, 3H); 7.12 (m, 1H); 7.00-6.98 (m, 1H); 5.08-5.06 (d, 1H); 5.00-4.99 (d, 1H); 4.96-4.95 (d, 1H); 4.91-4.90 (d, J=2.2 Hz, 1H); 4.59-4.57 (m, 1H); 3.68-3.58 (m, 2H); 3.54-3.31 (m, 3H); 3.21-3.15 (m, 1H).



13C-NMR [DMSO-d6]: 195.53, 137.91, 136.42, 135.63, 135.45, 133.59, 133.00, 132.45, 130.06, 128.34, 127.97, 127.88, 127.56, 127.32, 119.70, 119.36, 119.20, 115.82, 109.70, 100.63, 73.53, 73.00, 71.70, 70.01, 60.83.


1-(2-Benzoylphenyl)-6-chloro-1H-indol-3-yl-beta-D-glucuronide sodium salt (I21f)

Yield: 1.79 g (69%); TLC [toluene/ethanol (5:3)]: Rf 0.07.



1H-NMR [DMSO-d6]: 7.82-7.79 (m, 1H); 7.69-7.63 (m, 3H); 7.57-7.54 (m, 1H); 7.40-7.38 (m, 3H); 7.24-7.20 (m, 2H); 7.11 (m, 2H); 6.99-6.97 (m, 1H); 6.66 (br. s, 1H); 5.45 (br. s, 1H); 5.21 (br. s, 1H); 4.30 (br. s, 1H); 3.47-3.40 (m, 1H); 3.27-3.22 (m, 3H).



13C-NMR [DMSO-d6]: 195.39, 172.84, 138.69, 136.30, 135.61, 133.73, 133.09, 132.41, 129.94, 128.43, 128.02, 127.45, 127.40, 119.79, 119.62, 119.38, 118.31, 116.62, 116.57, 109.64, 103.96, 76.43, 73.93, 73.04, 71.92.


1-(2-Benzoylphenyl)-6-chloro-1H-indol-3-yl-N-acetyl-beta-D-galactosaminide (I21g)

Yield: 1.46 g (53%); TLC [toluene/ethanol (5:3)]: Rf 0.28.



1H-NMR [DMSO-d6]: 7.82-7.74 (m, 2H); 7.70-7.64 (m, 2H); 7.62 (d, NH); 7.43-7.35 (m, 3H); 7.24-7.17 (m, 3H); 7.09 (d, 1H); 7.02 (s, 1H); 6.98 (dd, 1H); 4.73 (d, 1H); 4.63 (t, 1H); 4.60 (d, 1H); 4.42 (d, 1H); 3.93 (q, 1H); 3.70 (t, 1H); 3.60-3.48 (m, 3H); 3.40-3.32 (m, 1H); 1.83 (s, 3H).



13C-NMR [DMSO-d6]: 195.5, 169.6, 162.3, 138.7, 136.34, 135.72, 133.70, 133.15, 132.45, 129.95, 128.5, 128.0, 127.55, 127.5, 120.0, 119.3, 118.8, 116.2, 109.8, 103.0, 75.55, 70.8, 67.3, 60.25, 52.0, 23.2.


1-(2-Benzoylphenyl)-5-bromo-4-chloro-1H-indol-3-yl-beta-D-galactopyranoside (I22a)

Yield: 1.14 g (39%); TLC [toluene/ethanol (5:3)]: Rf 0.48.



1H-NMR [DMSO-d6]: 7.83-7.79 (m, 1H); 7.71-7.61 (m, 3H); 7.46-7.42 (m, 3H); 7.34-7.32 (m, 1H); 7.28-7.24 (m, 2H); 7.16 (s, 1H); 7.00-6.98 (m, 1H); 4.96-4.95 (br. d, 1H); 4.84-4.82 (br. d, 1H); 4.66-4.65 (br. s, 1H); 4.53-4.52 (d, J=4.7 Hz, 1H); 4.38-4.35 (br. s, 1H); 3.72-3.70 (m, 1H); 3.61-3.54 (m, 3H); 3.48-3.43 (m, 2H).



13C-NMR [DMSO-d6]: 195.12, 137.81, 135.92, 135.55, 133.32, 133.23, 132.30, 129.88, 128.51, 128.35, 128.08, 127.69, 126.55, 123.38, 118.34, 116.70, 112.84, 110.64, 103.89, 75.41, 73.37, 70.18, 67.90, 60.10, 55.98.


1-(2-Benzoyl-5-chlorophenyl)-6-chloro-1H-indol-3-yl-beta-D-galactopyranoside (I23a)

Yield: 1.28 g (47%); TLC [toluene/ethanol (5:3)]: Rf 0.49.



1H-NMR [DMSO-d6]: 7.79 (s, 1H); 7.72 (m, 2H); 7.45-7.39 (m, 4H); 7.22-7.17 (m, 3H); 7.12 (s, 1H); 7.02-6.99 (m, 1H); 5.23-5.22 (d, 1H); 4.85-4.84 (d, 1H); 4.68-4.65 (m, 1H); 4.51-4.50 (d, 1H); 4.29 (br. s, 1H); 3.71-3.69 (m, 1H); 3.57-3.52 (m, 3H); 3.44-3.33 (m, 2H).



13C-NMR [DMSO-d6]: 194.51, 138.89, 137.74, 136.51, 135.38, 134.28, 133.64, 133.15, 131.65, 128.41, 128.05, 127.93, 127.66, 127.32, 120.05, 119.49, 119.24, 116.06, 109.84, 104.36, 75.49, 73.12, 70.23, 67.90, 60.19.


1-(2-Benzoyl-5-methoxyphenyl)-6-chloro-1H-indol-3-yl-beta-D-galactopyranoside (I24a)

Yield: 2.4 g (76%); TLC [toluene/ethanol (4:1)]: Rf 0.23.


FT-IR: 3367m, 2911w, 2853w, 1654s, 1600s, 1579m, 1499m, 1470m, 1448m, 1365m, 1264s, 1239s, 1118s, 1075s, 1022s, 975m, 923m, 872s, 750m, 703s.



1H-NMR [DMSO-d6]: 7.66 (d, J=8.6, 1 arom. H); 7.44 (d, J=8.5, 1 arom. H); 6.36-7.32 (m, 1 arom. H); 7.34 (s, 1 arom. H); 7.32 (s, 1 arom. H); 7.21-7.14 (m, 6 arom. H); 6.98 (dd, J=8.5, 1.8, 1 arom. H); 5.23 (d, J=4.9, OH); 4.85 (d, J=5.7, OH); 4.69 (t, J=5.5, OH); 4.51 (d, J=4.7, OH); 4.29 (br. s, H—C(1)Gal); 3.92 (s, OCH3); 3.71 (t, J=4.0, H—C(4)Gal); 3.60-3.53 (m, 3H—CGal); 3.46 (t, J=6.2, 1H—CGal); 3.39-3.34 (m, 1H—CGal).



13C-NMR [DMSO-d6]: 194.80 (s, C═O); 162.32 (s, C—OCH3); 138.58, 138.49, 136.35, 133.58 (4 s); 132.46, 132.14, 128.16, 127.67 (4 d); 127.48, 127.44 (2 s); 119.73 (d); 119.46 (s); 119.21, 116.35, 113.68, 112.35, 109.75 (5 d); 104.42 (d, C(1)Gal); 75.56, 73.17, 70.28, 68.00 (4 d, C(2-5)Gal); 60.32 (t, C(6)Gal); 55.87 (q, OCH3).


1-[2-(2,4-Dimethoxybenzoyl)phenyl]-1H-indol-3-yl-beta-D-galactopyranoside (I25a)

Yield: 1.28 g (48%); TLC [toluene/ethanol (5:3)]: Rf 0.45.



1H-NMR [DMSO-d6]: 7.70-7.65 (m, 1H); 7.55-7.47 (m, 4H); 7.09-6.95 (m, 5H); 6.26-6.23 (m, 2H); 5.25-5.23 (d, 1H); 4.86-4.84 (d, 1H); 4.69-4.66 (br. s, 1H); 4.51-4.50 (d, 1H); 4.33-4.31 (d, J=7.7 Hz, 1H); 3.69 (s, 3H); 3.61-3.54 (m, 4H); 3.44 (s, 3H); 3.48-3.41 (m, 1H); 3.39-3.34 (m, 1H).



13C-NMR [DMSO-d6]: 193.05, 163.77, 159.66, 138.91, 138.70, 136.42, 133.78, 131.89, 131.33, 128.95, 127.21, 126.78, 122.30, 120.45, 119.50, 119.02, 117.73, 115.10, 109.65, 105.23, 104.75, 97.55, 75.50, 73.18, 70.35, 68.01, 60.32, 55.41, 55.38.


1-[2-(2,4-Dimethoxybenzoyl)phenyl]-1H-indol-3-yl choline phosphate (I25d)

Yield: 0.92 g (68%); TLC [ethyl acetate/pyridine/acetic acid/water (30:25:5:15)]: Rf 0.46.



1H-NMR [DMSO-d6]: 7.68-7.62 (m, 1H); 7.48 (m, 2H); 7.43 (2 d, 2H); 7.20 (d, 1H); 7.10 (s, 1H); 7.05 (t, 1H); 7.02 (t, 1H); 6.94 (t, 1H); 6.35 (d, 1H); 6.32 (dd, 1H); 4.05 (m, 2H); 3.72 (s, 3H); 3.53 (s, 3H); 3.46 (t, 3J[H,P]=4.6 Hz, 2H); 3.03 (s, 9H).



13C-NMR [DMSO-d6]: 193.0, 164.1, 160.0, 157.0, 138.8, 136.7, 134.0 (d, J[C,P]=7.4 Hz), 133.6, 132.3, 131.3, 129.0, 127.0 (J[C,P]=2.4 Hz), 122.0, 121.6 (J[C,P]=6.3 Hz), 119.5, 118.9, 117.6, 116.1, 109.7, 105.7, 97.9, 65.4 (J[C,P]=4.8 Hz), 59.0 (J[C,P]=5.36 Hz), 55.5 (2 OCH3), 53.0.


4-Chloro-1-[2-(2,4-dimethoxybenzoyl)phenyl]-1H-indol-3-yl-beta-D-galactopyranoside (126a)

Yield: 1.76 g (62%); TLC [toluene/ethanol (5:3)]: Rf 0.54.



1H-NMR [DMSO-d6]: 7.70-7.66 (m, 1H); 7.58-7.53 (m, 2H); 7.49-7.47 (m, 1H); 7.12-7.10 (m, 1H); 7.02 (s, 1H); 7.01-6.99 (m, 1H); 6.96-6.93 (m, 2H); 6.34-6.29 (m, 2H); 4.85-4.83 (br. s, 2H); 4.67-4.64 (br. s, 1H); 4.53-4.52 (d, 1H); 4.48-4.46 (d, J=5.9 Hz, 1H); 3.73 (s, 3H); 3.72-3.70 (m, 1H); 3.64-3.55 (m, 3H); 3.48 (s, 3H); 3.46-3.38 (m, 2H).



13C-NMR [DMSO-d6]: 192.84, 163.99, 159.72, 139.25, 138.17, 135.77, 135.07, 131.92, 131.33, 128.91, 127.18, 123.74, 122.88, 119.84, 119.36, 116.86, 115.14, 108.77, 105.40, 103.94, 97.59, 75.50, 73.44, 70.32, 68.00, 60.24, 55.48, 55.40.


6-Chloro-1-[2-(2,4-dimethoxybenzoyl)phenyl]-1H-indol-3-yl-beta-D-galactopyranoside (I27a)

Yield: 1.88 g (66%); TLC [toluene/ethanol (5:3)]: Rf 0.45.



1H-NMR [DMSO-d6]: 7.72-7.67 (m, 1H); 7.57-7.56 (m, 2H); 7.52-7.50 (m, 2H); 7.12-7.10 (m, 1H); 7.02 (s, 1H); 7.00-6.98 (m, 2H); 6.31-6.26 (m, 2H); 5.27-5.26 (d, 1H); 4.87-4.86 (d, 1H); 4.69-4.66 (br. s, 1H); 4.52-4.51 (d, J=4.6 Hz, 1H); 4.38-4.35 (br. s, 1H); 3.71 (s, 3H); 3.70-3.68 (m, 1H); 3.60-3.55 (m, 3H); 3.48 (s, 3H); 3.48-3.43 (m, 2H).


13C-NMR [DMSO-d6]: 192.89, 163.89, 159.54, 138.89, 138.52, 135.69, 133.98, 131.92, 131.54, 129.06, 127.77, 127.21, 127.03, 119.36, 119.21, 119.18, 116.09, 109.42, 105.38, 104.68, 97.41, 75.59, 73.13, 70.30, 68.03, 60.36, 55.44, 55.32.


5-Bromo-4-chloro-1-[2-(2,4-dimethoxybenzoyl)phenyl]-1H-indol-3-yl-beta-D-galactopyranoside (I28a)

Yield: 2.17 g (67%); TLC [toluene/ethanol (5:3)]: Rf 0.58.



1H-NMR [DMSO-d6]: 7.72-7.67 (m, 1H); 7.61-7.49 (m, 3H); 7.34-7.31 (m, 1H); 7.12-7.10 (m, 1H); 7.06 (s, 1H); 6.88-6.86 (m, 1H); 6.34-6.31 (m, 1H); 6.28-6.27 (m, 1H); 4.95-4.94 (d, 1H); 4.85-4.84 (d, 1H); 4.67-4.64 (br. s, 1H); 4.53-4.52 (d, J=4.6 Hz, 1H); 4.45 (br. s, 1H); 3.73 (s, 3H); 3.72-3.70 (m, 1H); 3.64-3.51 (m, 3H); 3.47 (s, 3H); 3.46-3.37 (m, 2H).



13C-NMR [DMSO-d6]: 192.76, 163.98, 159.63, 139.30, 137.84, 135.27, 133.68, 131.82, 131.42, 128.97, 128.14, 127.24, 126.32, 123.33, 119.28, 118.17, 116.38, 112.51, 110.45, 105.40, 104.06, 97.48, 75.53, 73.36, 70.24, 67.99, 60.24, 55.48, 55.39.


1-[2-(5-Carboxylfuranoyl)phenyl]-6-chloro-1H-indol-3-yl-beta-D-galactopyranoside (I29a)

Yield: 0.99 g (36%); TLC [toluene/ethanol (5:3)]: Rf 0.



1H-NMR [CD3COOD]: 7.82-7.74 (m, 2H); 7.69-7.67 (m, 1H); 7.63-7.59 (m, 1H); 7.55-7.49 (m, 1H); 7.33-7.32 (m, 1H); 7.12 (s, 1H); 7.04-7.02 (m, 1H); 6.97-6.96 (d, 1H); 6.88-6.87 (d, 1H); 4.69-4.67 (d, J=7.2 Hz, 1H); 4.14-4.13 (d, 1H); 4.04-3.94 (m, 3H); 3.86-3.82 (m, 2H).



13C-NMR [CD3COOD]: 184.9, 154.0, 147.7, 139.6, 138.2, 135.2, 135.1, 133.6, 130.9, 129.8, 128.4, 127.8, 121.3, 120.6, 119.8, 119.5, 119.1, 116.6, 110.9, 104.3, 75.5, 73.9, 71.9, 69.8, 62.1.


6-Chloro-1-(2-furanoylphenyl)-1H-indol-3-yl-beta-D-galactopyranoside (I30a)

Yield: 1.65 g (66%); TLC [toluene/ethanol (5:3)]: Rf 0.38.



1H-NMR [DMSO-d6]: 7.84 (m, 1H), 7.80-7.76 (m, 1H); 7.72-7.70 (m, 1H); 7.64-7.57 (m, 3H); 7.18 (s, 1H); 7.10-7.03 (m, 3H); 6.54-6.53 (m, 1H); 5.28-5.27 (d, 1H); 4.87-4.85 (d, 1H); 4.66-4.63 (m, 1H); 4.52-4.51 (d, 1H); 4.47-4.45 (d, J=7.7 Hz, 1H); 3.71-3.69 (m, 1H); 3.63-3.53 (m, 3H); 3.48-3.41 (m, 2H).



13C-NMR [DMSO-d6]: 181.55, 151.01, 148.81, 138.58, 136.06, 135.24, 133.78, 132.32, 129.62, 127.83, 127.62, 127.56, 120.83, 119.85, 119.48, 119.42, 116.24, 112.61, 109.64, 104.50, 75.54, 73.16, 70.32, 68.00, 60.27.


6-Chloro-1-[2-(N-methylpyrrole-2-carbonyl)phenyl]-1H-indol-3-yl-beta-D-galactopyranoside (I31a)

Yield: 1.76 g (69%); TLC [toluene/ethanol (5:3)]: Rf 0.36.



1H-NMR [DMSO-d6]: 7.95 (m, 1H); 7.73-7.69 (m, 1H); 7.63-7.55 (m, 3H); 7.17 (m, 1H); 7.10 (s, 1H); 7.05-7.02 (m, 2H); 6.35-6.34 (m, 1H); 5.91-5.90 (m, 1H); 5.27-5.26 (d, 1H); 4.86-4.84 (d, 1H); 4.63-4.60 (br. s, 1H); 4.51-4.50 (d, 1H); 4.45-4.43 (d, J=7.7 Hz, 1H); 3.71-3.68 (m, 1H); 3.61-3.33 (m, 5H); 2.88 (s, 3H).



13C-NMR [DMSO-d6]: 183.78, 162.23, 138.49, 137.27, 135.67, 133.72, 132.73, 131.16, 129.86, 129.41, 127.44, 127.34, 127.18, 121.99, 119.62, 119.34, 116.07, 109.87, 108.05, 104.62, 75.42, 73.14, 70.29, 67.86, 60.08, 36.40.


Example 2
Preparation of I19c and I25c by N-arylation of I1c (Table Ia)

5.0 mMol aryliodide, 1.31 g (7.48 mMol) I1c and 0.67 g (5.47 mMol) copper(I) acetate in 25 ml dry dimethylacetamide were heated to 150° C. for two hours under a nitrogen atmosphere. The product mixture was cooled to room temperature and diluted with 25 ml ethyl acetate. The suspension was poured onto 50 ml saturated aqueous ammoniumchloride solution and stirred for 30 minutes. The organic phase was washed with brine, dried with sodium sulfate, filtered and evaporated to dryness. The resulting oil was purified by column chromatography on silica gel [toluene; toluene/acetone (10:1)].


1-(2-Benzoylphenyl)-1H-indol-3-yl acetate (I19c)

Yield: 590 mg (33%); TLC (toluene): Rf 0.15.



1H-NMR [DMSO-d6]: 7.83-7.79 (m, 1H); 7.71-7.64 (m, 3H); 7.42-7.36 (m, 3H); 7.32-7.30 (m, 1H); 7.26-7.25 (m, 1H); 7.23-7.11 (m, 4H); 7.05-7.01 (m, 1H); 2.27 (s, 3H).



13C-NMR [DMSO-d6]: 195.27, 168.03, 136.36, 135.78, 135.63, 133.41, 133.08, 132.23, 130.69, 129.91, 128.49, 128.11, 127.94, 127.61, 122.89, 120.24, 120.04, 118.37, 117.35, 110.27, 20.46.


1-[2-(2,4-Dimethoxybenzoyl)phenyl]-1H-indol-3-yl acetate (I25c)

Yield: 1.23 g (59%); TLC [toluene/acetone (10:1)]: Rf 0.66.



1H-NMR [DMSO-d6]: 7.71-7.67 (m, 1H); 7.56-7.52 (m, 3H); 7.37-7.35 (m, 1H); 7.31 (s, 1H); 7.18-7.16 (m, 1H); 7.14-7.10 (m, 3H); 7.06-7.02 (m, 1H); 6.30 (s, 1H); 3.70 (s, 3H); 3.49 (s, 3H); 2.30 (s, 3H).



13C-NMR [DMSO-d6]: 192.77, 167.99, 163.99, 139.07, 135.72, 133.60, 131.92, 131.31, 130.42, 128.92, 128.79, 128.09, 127.65, 127.13, 125.21, 122.64, 119.75, 118.24, 117.16, 110.09, 105.52, 97.58, 55.38, 55.33, 20.51.


Example 3
Preparation of 132 by N-arylation of 16 (Table Ia)
1-(2-Benzoylphenyl)-1H-indol-3-yl ethyl carbamate (I32)

1.30 g (4.22 mMol) 2-iodobenzophenone, 1.29 g (6.32 mMol) 3-aminoindol-3-ethylcarbamate and 0.57 g (4.65 mMol) copper(I) acetate in 25 ml dry dimethylacetamide were heated to 150° C. for two hours under a nitrogen atmosphere. The product mixture was cooled to room temperature and diluted with 25 ml ethyl acetate. The suspension was poured onto 50 ml saturated aqueous ammoniumchloride solution and stirred for 30 minutes. The organic phase was washed with brine, dried with sodium sulfate, filtered and evaporated to dryness. The resulting oil was purified by column chromatography on silica gel [toluene; toluene/acetone (10:1)].


Yield: 100 mg (6%); TLC [toluene]: Rf 0.10.



1H-NMR [DMSO-d6]: 9.50 (s, NH); 7.81-7.77 (m, 1H); 7.71-7.60 (m, 4H); 7.41-7.36 (m, 4H); 7.20-7.16 (m, 3H); 7.11-7.07 (m, 1H); 6.99-6.95 (m, 1H); 4.13 (q, 2H); 1.24 (t, 3H).



13C-NMR [DMSO-d6]: 195.42, 153.57, 136.98, 135.73, 135.43, 133.92, 132.95, 132.15, 129.89, 128.42, 127.86, 127.43, 127.13, 122.59, 121.06, 119.21, 118.44, 117.53, 117.08, 109.78, 60.15, 14.53.


Example 4
Preparation of bis[1-(2-acetylphenyl)-1H-indol-3-yl]-disulfane (I33, Table Ia
1-(2-Acetylphenyl)-1H-indol-3-yl-isothiuronium iodide

1.80 g (7.65 mMol) 1-(2-acetylphenyl)-1H-indole (prepared by the method of Example 1) and 1.17 g thiourea (15.4 mMol) were dissolved in a mixture of 35 ml methanol (35 ml) and 4 ml water. 3.90 g iodine (15.4 mMol) was dissolved in a solution of potassium iodide (3.82 g, 23 mMol) in water (7.7 ml). This iodine solution was added dropwise to the solution above at ambient temperature during an hour and warmed to 35° C. for three hours. Solvents were removed by evaporation. The residual oil was dissolved in ethyl acetate (40 ml). The solution was extracted three times with water (3×10 ml). The organic layer was dried and treated with charcoal (1 g). The crude product was obtained after evaporation of the filtrate and purified by column chromatography on silica gel (100 g, ethyl acetate).


Yield: 1.27 g (38%).



1H-NMR [DMSO-d6]: 9.06 (s, NH2); 8.62 (s, NH2); 8.18 (s, 1H); 7.98 (d, 1H); 7.84 (t, 1H); 7.70 (2 t, 2×1H); 7.61 (m, 1H); 7.30 (m, 2H); 7.12 (m, 1H); 2.18 (s, 3H).



13C-NMR [DMSO-d6]: 199.4, 170.2, 139.3, 137.8, 136.2, 135.0, 133.1, 129.9, 129.3, 129.0, 128.5, 123.9, 122.0, 118.2, 111.0, 92.6, 29.0


Bis[1-(2-acetylphenyl)-1H-indol-3-yl]-disulfane (I33)

1-(2-Acetylphenyl)-1H-indol-3-yl-isothiuronium iodide (0.47 g, 1.07 mMol) was dissolved in a mixture of degassed dioxane (2.7 ml) and degassed water (1.57 ml) under a nitrogen atmosphere.


A degassed 5% aqueous solution of sodium hydroxide (0.8 ml, 1.22 mMol) was added dropwise at ambient temperature, whereby the solution turned dark-brown. The solution was stirred for 48 hours at 45° C. The product mixture was evaporated, dissolved in water (5 ml) and extracted with ethyl acetate. The organic layers were dried over sodium sulfate and evaporated leaving the crude product as viscous oil which was purified by silica gel flash chromatography.


Yield: 70 mg (24%).



1H-NMR [DMSO-d6]: 7.84 (dd, 1H); 7.66 (dt, 1H); 7.62 (dt, 1H); 7.60 (d, 1H); 7.55 (s, 1H); 7.38 (d, 1H); 7.19 (2 t, 2×1 H); 7.03 (d, 1H); 1.94 (s, 3H).



13C-NMR [DMSO-d6]: 199.1, 137.5, 136.4, 135.3, 132.8, 129.6, 128.8, 128.7, 128.5, 123.5, 121.3, 119.3, 110.4, 108.0, 28.4.


Example 5
Preparation of 10H-indolo[1,2-a]indoles (Table Ic)

Enzymatic reactions were performed in 100 mM Na2PO4 buffer, pH 7.3 containing 1 mM MgCl2 and 670 mg/l enzyme substrate. E. coli beta-galactosidase or K. lactis lactase were added to a final concentration of 1000 U/I or 1500 U/I, respectively. 30 ml reaction volumes were incubated for 5-18 hours at 37° C. with gentle shaking. The reaction product was collected by centrifugation (4400 g, 15 min), pellets were washed with 10 ml H2O and centrifuged again (4400 g, 15 min).


11-Hydroxy-10H-indolo[1,2-a]indol-10-one (IO10)


1H-NMR [DMSO-d6]: 7.73 (d, J=8.2 Hz, 2 arom. H); 7.69 (d, J=7.7 Hz, 2 arom. H); 7.50 (t, J=7.3 Hz, 2 arom. H); 7.07 (t, J=7.5 Hz, 2 arom. H); 5.79 (br. s).



13C-NMR [DMSO-d6]: 160.75 (s, C═O); 138.32 (s, arom. C); 132.10 (d, arom. C—H); 127.15 (s, arom. C); 123.27, 121.52 (2 d, arom. C—H); 118.65 (s, C(10a); 111.72 (d, arom. C—H).


Note: IO10 turns to be readily water-soluble above a pH of 5.


10H-Indolo[1,2-a]indol-10-one (IO13)


1H-NMR [DMSO-d6]: 7.94 (m, 1H); 7.84 (m, 1H); 7.74 (m, 1H); 7.67 (m, 1H); 7.62 (m, 1H); 7.48 (m, 1H); 7.35 (m, 1H); 7.18 (m, 1H); 7.17 (m, 1H).



13C-NMR [DMSO-d6]: 180.7, 144.8, 136.3, 135.0, 133.7, 132.0, 128.5, 128.4, 124.9, 124.7, 124.3, 122.2, 112.2, 112.0, 108.1.


MS (CI): 220.2 ([M+H]+).


11-Methyl-10H-indolo[1,2-a]indol-10-one (IO14)


1H-NMR [DMSO-d6]: 7.85 (m, 1H); 7.77 (m, 1H); 7.71 (m, 1H); 7.62 (m, 1H); 7.59 (m, 1H); 7.47 (m, 1H); 7.16 (m, 1H); 7.13 (m, 1H); 2.50 (s, 3H).



13C-NMR [DMSO-d6]: 180.8, 144.0, 135.8, 133.3, 132.6, 131.7, 128.6, 128.5, 124.1, 123.4, 122.8, 121.5, 121.3, 111.7, 111.6, 8.8.


UV: λmax=255, 355, 435 nm.


9-Chloro-1′-methyl-10H-indolo[1,2-a]indol-10-one (IO15)


1H-NMR [DMSO-d6]: 7.88-7.86 (m, 1H); 7.76-7.72 (m, 2H); 7.60-7.56 (m, 1H); 7.51-7.47 (m, 1H); 7.21-7.17 (m, 1H); 7.12-7.10 (m, 1H); 2.49 (s, 3H).



13C-NMR [DMSO-d6]: 178.3, 145.6, 136.8, 133.2, 133.0, 132.3, 130.8, 128.8, 124.8, 124.3, 123.0, 122.2, 121.9, 112.0, 110.8, 8.9.


UV: λmax=245, 365, 440 nm.


7-Chloro-11-methyl-10H-indolo[1,2-a]indol-10-one (IO16)


1H-NMR [DMSO-d6]: 8.00-7.98 (m, 1H); 7.92 (m, 1H); 7.73-7.71 (m, 1H); 7.58-7.56 (m, 1H); 7.50-7.46 (m, 1H); 7.20-7.15 (m, 2H); 2.48 (s, 3H).



13C-NMR [DMSO-d6]: 179.9, 144.8, 140.4, 133.4, 132.9, 132.1, 128.9, 127.7, 125.6, 123.5, 123.0, 122.6, 122.0, 112.24, 112.21, 9.00.


UV: λmax=245, 360, 430 nm.


8-Bromo-9-chloro-11-methyl-10H-indolo[1,2-a]indol-10-one (IO17)


1H-NMR [DMSO-d6]: 7.96-7.94 (m, 1H); 7.90-7.87 (m, 1H); 7.76-7.72 (m, 2H); 7.53-7.48 (m, 1H); 7.22-7.18 (m, 1H); 2.50 (s, 3H).



13C-NMR [DMSO-d6]: 177.3, 144.6, 139.5, 133.2, 132.9, 131.9, 130.7, 129.2, 126.0, 123.2, 123.1, 122.2, 116.9, 112.2, 112.1, 9.0.


UV: λmax=245, 365, 450 nm.


7-Chloro-3-methoxy-11-methyl-10H-indolo[1,2-a]indol-10-one (IO18)


1H-NMR [DMSO-d6]: 8.07 (d, J=1.6, 1 H); 7.61 (d, J=8.8, 1 H); 7.56 (d, J=8.0, 1H); 7.39 (d, J=2.1, 1 H); 7.17 (dd, J=8.0, 1.6, 1 H); 6.80 (dd, J=8.8, 2.2, 1 H); 3.94 (s, OCH3); 2.46 (s, CH3).


11-Phenyl-10H-indolo[1,2-a]indol-10-one (IO19)


1H-NMR [DMSO-d6]: 8.04-8.02 (m, 1H); 7.99-7.92 (m, 4H); 7.71-7.65 (m, 2H); 7.59-7.55 (m, 3H); 7.51-7.47 (m, 1H); 7.29-7.19 (m, 2H).



13C-NMR [DMSO-d6]: 180.1, 144.0, 136.0, 133.9, 130.7, 130.2, 128.9, 128.8, 124.6, 124.5, 124.3, 123.7, 122.7, 112.4, 112.3.


UV: λmax=245, 370, 460 nm.


9-Chloro-11-phenyl-10H-indolo[1,2-a]indol-10-one (IO20)


1H-NMR [DMSO-d6]: 8.05-8.03 (m, 1H); 7.97-7.90 (m, 4H); 7.67-7.63 (m, 1H); 7.59-7.55 (m, 3H); 7.51-7.49 (m, 1H); 7.31-7.27 (m, 1H); 7.20-7.18 (m, 1H).



13C-NMR [DMSO-d6]: 145.5, 137.0, 133.7, 131.0, 130.5, 129.0, 128.8, 125.4, 124.9, 124.4, 123.8, 123.1, 112.6, 111.1.


8-Bromo-9-chloro-11-phenyl-10H-indolo[1,2-a]indol-10-one (IO22)


1H-NMR [DMSO-d6]: 8.04-8.00 (m, 2H); 7.98-7.92 (m, 3H); 7.89-7.86 (m, 1H); 7.60-7.48 (m, 4H); 7.31-7.28 (m, 1H).



13C-NMR [DMSO-d6]: 144.3, 139.5, 133.7, 131.0, 130.4, 130.2, 129.0, 128.9, 128.7, 126.2, 125.4, 123.9, 123.1, 117.5, 112.6, 112.5.


7-Chloro-3-methoxy-11-phenyl-10H-indolo[1,2-a]indol-10-one (IO24)


1H-NMR [DMSO-d6]: 8.13 (d, J=1.6, 1 H); 7.94, 7.92 (2 br. s, 2H); 7.77 (d, J=9.0, 1 H); 7.59 (d, J=8.0, 1 H); 7.54 (br. t, J=8.0, 2 H); 7.48-7.44 (m, 2H); 7.21 (dd, J=8.0, 1.6, 1 H); 6.87 (dd, J=9.0, 2.2, 1 H); 3.37 (s, OCH3).


11-(5-Carboxyfuran-2-yl)-7-chloro-10H-indolo[1,2-a]indol-10-one (IO29)


1H-NMR [DMSO-d6]: 8.57-8.54 (m, 1H); 8.08-8.06 (m, 1H); 8.00 (m, 1H); 7.84 (m, 1H); 7.71-7.69 (m, 1H); 7.61-7.57 (m, 1H); 7.36-7.33 (m, 1H); 7.26-7.24 (m, 1H); 6.85-6.84 (m, 1H).


7-Chloro-11-(furan-2-yl)-10H-indolo[1,2-a]indol-10-one (IO30)


1H-NMR [DMSO-d6]: 8.33-8.30 (m, 1H); 8.16-8.14 (m, 1H); 8.09 (m, 1H); 8.03 (m, 1H); 7.86-7.83 (m, 1H); 7.70-7.68 (m, 1H); 7.60-7.56 (m, 1H); 7.34-7.31 (m, 1H); 7.27-7.25 (m, 1H); 6.82-6.81 (m, 1H).



13C-NMR [DMSO-d6]: 177.7, 148.0, 145.0, 144.2, 140.2, 133.9, 129.4, 128.3, 127.4, 125.8, 125.2, 124.0, 123.1, 114.0, 113.2, 112.7, 112.6, 112.4.


Conclusion: IO stains are produced efficiently from corresponding indicators subjected to enzymatic external stimuli (eS).


Example 6
Optical absorption of 10H-indolo[1,2-a]indoles (FIG. 1)

Dried 10H-Indolo[1,2-a]indole pellets obtained from procedures of example 5 were dissolved in ethanol/DMF (1:1) at 2.5 mM. This stock solution was diluted to 0.22 mM in 100% EtOH and a spectral scan was recorded on a Spectramax M5 (Molecular Devices). The spectra of the corresponding indicators were recorded for comparison. Data are shown in FIG. 1.


Absorption spectra of Indicators and corresponding IO stains are substantially different in the visible band.


Conclusion: IO staining produces strong and readily detectable signals.


Example 7
In-Vitro Indication of Fluoride and Hydroxide Ions with Indicator Systems I4b/MDAB and I4c/MDAB

I4b (0.4 g, 1.11 mMol) and MDAB (0.25 g, 1.39 mMol) were dissolved in ethanol (8 ml). The resulting indicator solution was kept under an atmosphere of nitrogen gas. A 1 mM solution of tetrabutylammonium fluoride in THF (1.6 ml) was added to the indicator solution at room temperature. After 10 minutes BI4 precipitated as intensely violet heavy solid which was collected and dried (0.19 g, 42%). Similarly, BI4 was obtained by exposing I4c/MDAB to aqueous base.



1H-NMR [DMSO-d6]: 9.84 (s, H1); 7.68 (d, J=8.6 Hz, H6); 7.61 (d, J=8.8 Hz, H6″); 7.07 (s, ═CH—); 7.02 (d, J=8.6 Hz, H7); 6.38 (dd, J=8.8 Hz, H5″); 6.24 (d, H3″); 3.88 (s, OCH3); 3.02 (s, N(CH3)2).



13C-NMR [DMSO-d6]: 181.0 (C═O), 160.0, 152.8, 152.5, 138.3, 130.74, 130.71, 129.9, 118.3, 113.0, 111.4, 110.0, 109.1, 104.9, 94.6 (OCH3), 55.5 (N(CH3)2).


Note: There are two possible stereoisomers of BI4, (E)-5-bromo-4-chloro-2-(4-dimethylamino-2-methoxybenzylidene)indolin-3-one and (Z)-5-bromo-4-chloro-2-(4-dimethylamino-2-methoxybenzylidene)indolin-3-one. NOE NMR measurements indicate that only (Z)-BI4 was formed in the process.


Conclusion: (1) indicator system I4b/MDAB is potentially useful for the anaerobic detection of fluoride ions and (2) indicator system I4c/MDAB is potentially useful for the irreversible detection of transient alkaline pH conditions (common pH indicators allow reversible detection only).


Example 8
Reaction of MDAB with indol-3-amine (aS6) and indol-3-thiole (aS7)

Exposure of active signalogen aS6 (prepared by reduction of the corresponding nitroso compound) to atmospheric oxygen yielded a polymeric brown precipitate rather than the bis-imino-indigo derivative. In the presence of MDAB and in the absence of oxygen aS6 produced yellow color probably the Schiff base which, however, escaped isolation. Formation of the expected hetero aldol product was not observed.


Exposure of active signalogen aS7 (obtained in analogy to 133) to oxygen yields the corresponding disulfane rather than the bis-thion-indigo analogue. In the presence of MDAB and in the absence of oxygen the expected violet color appeared only under strongly acidic conditions.


Conclusion: MDAB staining may not be suitable for indicators derived of indol-3-amines or indol-3-thiols.


Example 9a
MDAB Staining of Bacterial Colonies with Indicators I4a and I5a (Table III, entries 1-25)

Tryptic Soy Agar (TSA) with yeast extract (0.6%) was used as the base plating medium. The media were autoclaved at 121° C. for 15 minutes and placed in a 50° C. water bath to cool. Indicators were added to the basal medium at a final concentration of 40 mg/100 ml (from 80 mg/ml stock solutions in DMF). Over night cultures of enteric bacterial cells in Brain Heart Infusion Broth were streaked onto the plates and incubated at 35° C. for 24 hours under aerobic and anaerobic conditions. After incubation, the colonial morphologies on the plates were recorded (Table III).


Under anaerobic conditions and in the absence of MDAB indicators tested failed to stain bacterial colonies producing suitable external stimulus (beta-D-galactosidase). Weak staining was observed occasionally due to residual oxygen (micro-anaerobic conditions). Under aerobic conditions indigo (IN-stains) generally dominated the effects of MDAB staining. For example indicator system I4a/MDAB stained colonies violet under anaerobic but indigo blue under aerobic conditions.


Conclusion: MDAB staining is a potentially valuable method for detection and isolation of microbial species especially under anaerobic conditions.


Note: 4-(N,N-Dimethyl)aminobenzaldehyde (DAB) and a large number of other potentially suitable Adol acceptors selected from the group of aromatic carbonyl compounds did not produce any BI-stains under all conditions tested when used to replace MDAB.


Example 9b
MDAB staining of bacterial colonies with indicators I9a, I10a, I11a and I12a (Table III, entries 26-37)

Indicators were tested with live cultures on Nutrient Agar plates. Nutrient Agar (5 g/l peptone, 5 g/l NaCl, 2 g/l yeast extract, 1 g/l beef extract, 13 g/l agar, pH 7.4) was autoclaved and allowed to cool to 50° C. Then substrates were added to final concentrations of 150 mg/l (from a 20 mg/ml stock solution in DMF). Optionally MDAB was added to a concentration of 1 mM (from a 200 mM stock solution in DMF) and plates were poured. Agar plates were inoculated with cultures of Eschericha coli (NM1) or Salmonella enteritidis (RKI 05/07992) (pre-grown on nutrient broth for 8-18 hours) and aerobically incubated at 37° C. Results were recorded after 48 h of incubation and are shown in Table III.


Conclusion: Indicators I9a, I11a and I12a are potentially useful for MDAB staining under aerobic conditions.


Example 10
10H-Indolo[1,2-a]indole (10) staining of bacterial colonies (Table IVa-c)

Nutrient Agar (5 g/l peptone, 5 g/l NaCl, 2 g/l yeast extract, 1 g/l beef extract, 13 g/l agar, pH 7.4) was autoclaved and allowed to cool to 50° C. Then indicators were added to final concentrations of 150 mg/l (from a 20 mg/ml stock solution in DMF).


Optionally IPTG was added to 100 mg/l (from a 100 mg/ml stock solution in H2O) and plates were poured. Agar plates were inoculated with cultures of beta-galactosidase positive Eschericha coli (NM1) or beta-galactosidase negative Salmonella enteritidis (RKI 05/07992) (pre-grown on nutrient broth for 8-18 hours) and incubated at 37° C. Plates were inspected at 16, 20, 24 and 48 hours and pictures were recorded at 18, 24, and 48 hours with a Digistore 2 Image documentation system (CAMAG) under white light. Data are shown in Tables IVa, IVb and IVc.


A considerable number of indicators molecules (Table IVa, IVb) and a selection of labile groups (Table IVc) were tested with various microbial species producing different biomarker enzymes (external stimuli, eS). The color of stains ranges from yellow to red. Some stains tested show excellent localization of external stimuli (enzyme activity) while others were significantly soluble in the medium and may be of use for solution based assay (Table IVa). Staining is accompanied by fluorescence while green fluorescence was observed to be of transient nature, (caused by fluorescence of the active Signalogen) 10H-indolo[1,2-a]indoles fluorescence at longer wavelength (yellow-red) was stable.


Conclusion: IO staining is a potentially valuable method for detection and isolation of microbial species providing a new color scheme, long wave fluorescence and complete independence of auxiliary reagents (aR) potentially interfering with the assay.


Example 11
Indigo (IN) and 10H-indolo[1,2-a]indole (10) concurrent staining (Table IVd)

Nutrient Agar containing 150 mg/l 1-(2-benzoylphenyl)-6-chloro-1H-indol-3-yl-beta-D-galactopyranoside (I21a), 100 mg/l IPTG and 75 mg/l 5-bromo-4-chloro-1H-indol-3-yl-beta-D-glucopyranoside (I4h) was inoculated with Escherichia coli, Klebsiella pneumoniae, Enterococcus faecalis and Enterobacter aerogenes. Data collected after 24 h of incubation at 37° C. are given in Table IVd. Microbial colonies producing both beta-D-galactosidase and beta-D-glucosidase appeared green due to parallel formation of blue IN and the yellow IO stains.


Conclusion: The combination of complementary IN and IO staining is potentially useful to extend the currently available color scheme.


Example 12
IN and IO staining of bacterial colonies under anaerobic conditions (Table IVe)

Nutrient Agar plates containing 150 mg/l of various substrates and 100 mg/l IPTG were inoculated with Escherichia coli. Plates were put in an anaerobic jar (Anaerojar, Oxoid), an AnaeroGen sachet (Oxoid) was added, the jar was closed and incubated for 24 hours at 37° C. Data were recorded and are shown in Table IVe.


IN staining cannot be used under anaerobic conditions. While due to slower colonial growth diffusion of some IO stains increases under anaerobic conditions other stains such as 1022 produced from indicator I22a provide perfect localization.


Conclusion: IO staining is a potentially valuable technique for use under micro-aerobic or anaerobic conditions.


Example 13
IO Staining of Bacterial Colonies on Blood Agar Plates (Table IVf)

Standard commercially available Blood Agar plates were impregnated with 150 mg/l 1-(2-benzoylphenyl)-6-chloro-1H-indol-3-yl-beta-D-galactopyranoside (I21a) and 100 mg/l IPTG. The plate was inoculated with Klebsiella pneumoniae. Results after incubation at 37° C. for 24 hours are given in Table IVf.


IO stain contrasts very well with the agar plate. Further, despite the quenching effect of blood 10 fluorescence is fully maintained and readily detectable.


Conclusion: IO staining is potentially valuable for use in microbial blood culture.


Example 14
IO Staining of Fungal Colonies (Table IVg)

Agar base (6 g/l soytone, 1.5 g/l yeast extract, 1 g/l glucose, 10 mM sodium phosphate buffer, 13 g/l agar, pH 7.0) was autoclaved and allowed to cool to 50° C. Then 1 mM MnSO4, 1 g/l N-Acetyl-D-galactosamine and: 1-(2-benzoylphenyl)-6-chloro-1H-indol-3-yl-N-acetyl-beta-D-galactosaminide (I21g) were added to final concentrations of 0.64 mM (from a 50 mM stock solution in DMF) and plates poured. Plates were inoculated with Candida albicans, Candida krusei and Saccharomyces cerevisiae and incubated at 37° C. for 48 hours. Results were recorded and are shown in Table IVg.


Example 15
Fluorescence of 10H-indolo[1,2-a]indoles stained microbial cells (FIG. 2)

Plating media from Example 10 were examined under 366 nm UV irradiation at 16, 20, 24 and 48 hours for fluorescence by means of Digistore 2 Image documentation system (CAMAG). Data are shown in Tables IVa, IVb and IVc. Loops of bacterial cells, grown for 48 hours on Nutrient Agar plates containing 150 mg/l beta-D-galactosidase indicator and 100 mg/l IPTG, were directly streaked into wells of black clear bottom microtiter plates. Fluorescence scans were recorded on a Spectramax M5 (Molecular Devices). Data are shown in FIG. 2. Stained cells were shown to be detectable under a standard fluorescence microscope.


IO staining is accompanied by significant fluorescence. While green fluorescence observed appeared to be of transient nature, (caused by fluorescence of the active 1H-indol-3-yl signalogen) 10 fluorescence at longer wavelengths (yellow-red) was found to be persistent.


Conclusion: IO staining represents a potentially valuable method for detection and isolation of microbial species providing a means of long wave fluorescence staining of live microbial colonies and a novel simple tool for fluorescence labeling of individual cells.


Example 16
Indication of Carbamate Hydrolysis

When 1-(2-benzoylphenyl)-1H-indol-3-yl ethyl carbamate (I32) was subjected to short treatment with 1N aqueous NaOH solution or prolonged exposure to pig liver esterase a yellow precipitate was produced which was identified as 11-phenyl-10H-indolo[1,2-a]indol-10-one (IO19) by TLC comparison with reference samples.


Apparently, 11-phenyl-10H-indolo[1,2-a]indol-10-imine (I032), which is expected to yield from the aldol condensation is rapidly hydrolyzed to IO19.


Conclusion: The concept of IO staining can be expanded to include indicators producing 1-(2-benzoylphenyl)-1H-indol-3-amine (aS32) or similar active signalogens hence providing the potential design for long sought precipitating indicators for amino-peptidase enzymes.


Example 17
Indication of Disulfide Reduction

Bis[1-(2-acetylphenyl)-1H-indol-3-yl]-disulfane (I33, 2 mg) was dissolved in methanol (0.5 ml). Tris(2-carboxyethyl)phosphine hydrochloride (TCEP, 20 mg) was added to the almost colorless solution. Upon subsequent addition of 1 N aqueous sodium hydroxide solution the solution turned yellow.


Conclusion: (1) IO staining/indication is potentially useful for detection reducing environments and (2) the concept of IO staining can potentially be expanded to include indicators producing 1-(2-acetylphenyl)-1H-indol-3-thiol (aS33) or similar active signalogens.









TABLE Ia







List of 1H-Indol-3-yl Indicators









Chemical Structure of Indicator (R4 = H)





















Entry
Code
Indicator
LG
aS
R1
R2
R3
R5
X
R6
R7
R8
R9
R10
























1
I1a
1H-Indol-3-yl-beta-D-
a
1
H
H
H
H
O









galactopyranoside


2
I1c
1H-Indol-3-yl acetate
c
1
H
H
H
H
O







3
I2a
4-Chloro-1H-indol-3-yl-beta-
a
2
Cl
H
H
H
O









D-galactopyranoside


4
I3a
6-Chloro-1H-indol-3-yl-beta-
a
3
H
H
Cl
H
O









D-galactopyranoside


5
I3e
6-Chloro-1H-indol-3-yl-alpha-
e
3
H
H
Cl
H
O









D-glucopyranoside


6
I3f
6-Chloro-1H-indol-3-yl-beta-
f
3
H
H
Cl
H
O









D-glucuronide sodium salt


7
I3g
6-Chloro-1H-indol-3-yl-N-
g
3
H
H
Cl
H
O









acetyl-beta-D-




galactosaminide


8
I4a
5-Bromo-4-chloro-1H-indol-3-
a
4
Cl
Br
H
H
O









yl-beta-D-galactopyranoside


9
I4b
5-Bromo-3-(tert-
b
4
Cl
Br
H
H
O









butyldimethylsilyloxy)-4-




chloro-1H-indole


10
I4c
5-Bromo-4-chloro-1H-indol-3-
c
4
Cl
Br
H
H
O









yl acetate


11
I4d
5-Bromo-4-chloro-1H-indol-3-
d
4
Cl
Br
H
H
O









yl choline phosphate


12
I4h
5-Bromo-4-chloro-1H-indol-3-
h
4
Cl
Br
H
H
O









yl-beta-D-glucopyranoside


13
I5a
5-Bromo-6-chloro-1H-indol-3-
a
5
H
Br
Cl
H
O









yl-beta-D-galactopyranoside


14
I6-
1H-Indol-3-yl-ethyl carbamate
1)
6
H
H
H
H
N







15
I8a
1-Phenyl-1H-indol-3-yl-beta-
a
8
H
H
H
R11
O
H
H
H
H
H




D-galactopyranoside


16
I9a
6-Chloro-1-phenyl-1H-indol-
a
9
H
H
Cl
R11
O
H
H
H
H
H




3-yl-beta-D-




galactopyranoside


17
I10a
1-[2-(Methoxy-
a
10
H
H
H
R12
O
H
H
H
H
OMe




carbonyl)phenyl]-1H-indol-3-




yl-beta-D-galactopyranoside


18
I11a
6-Chloro-1-[2-(methoxy-
a
11
H
H
Cl
R12
O
H
H
H
H
OMe




carbonyl)phenyl]-1H-indol-3-




yl-beta-D-galactopyranoside


19
I12a
5-Bromo-4-chloro-1-[2-
a
12
Cl
Br
H
R12
O
H
H
H
H
OMe




(methoxycarbonyl)phenyl]-




1H-indol-3-yl-beta-D-




galactopyranoside


20
I13a
1-(2-Formylphenyl)-1H-indol-
a
13
H
H
H
R12
O
H
H
H
H
H




3-yl-beta-D-




galactopyranoside


21
I14a
1-(2-Acetylphenyl)-1H-indol-
a
14
H
H
H
R12
O
H
H
H
H
Me




3-yl-beta-D-




galactopyranoside


22
I15a
1-(2-Acetylphenyl)-4-chloro-
a
15
Cl
H
H
R12
O
H
H
H
H
Me




1H-indol-3-yl-beta-D-




galactopyranoside


23
I16a
1-(2-Acetylphenyl)-6-chloro-
a
16
H
H
Cl
R12
O
H
H
H
H
Me




1H-indol-3-yl-beta-D-




galactopyranoside


24
I17a
1-(2-Acetylphenyl)-5-bromo-
a
17
Cl
Br
H
R12
O
H
H
H
H
Me




4-chloro-1H-indol-3-yl-beta-




D-galactopyranoside


25
I18a
1-(2-Acetyl-5-methoxy-
a
18
H
H
Cl
R12
O
H
OMe
H
H
Me




phenyl)-6-chloro-1H-indol-3-




yl-beta-D-galactopyranoside


26
I19a
1-(2-Benzoylphenyl)-1H-
a
19
H
H
H
R12
O
H
H
H
H
Phe




indol-3-yl-beta-D-




galactopyranoside


27
I19c
1-(2-Benzoylphenyl)-1H-
c
19
H
H
H
R12
O
H
H
H
H
Phe




indol-3-yl acetate


28
I20a
1-(2-Benzoylphenyl)-4-chloro-
a
20
Cl
H
H
R12
O
H
H
H
H
Phe




1H-indol-3-yl-beta-D-




galactopyranoside


29
I21a
1-(2-Benzoylphenyl)-6-chloro-
a
21
H
H
Cl
R12
O
H
H
H
H
Phe




1H-indol-3-yl-beta-D-




galactopyranoside


30
I21e
1-(2-Benzoylphenyl)-6-chloro-
e
21
H
H
Cl
R12
O
H
H
H
H
Phe




1H-indol-3-yl-alpha-D-




glucopyranoside


31
I21f
1-(2-Benzoylphenyl)-6-chloro-
f
21
H
H
Cl
R12
O
H
H
H
H
Phe




1H-indol-3-yl-beta-D-




glucuronide sodium salt


32
I21g
1-(2-Benzoylphenyl)-6-chloro-
g
21
H
H
Cl
R12
O
H
H
H
H
Phe




1H-indol-3-yl-N-acetyl-beta-




D-galactosaminide


33
I22a
1-(2-Benzoylphenyl)-5-
a
22
Cl
Br
H
R12
O
H
H
H
H
Phe




bromo-4-chloro-1H-indol-3-yl-




beta-D-galactopyranoside


34
I23a
1-(2-Benzoyl-5-chlorphenyl)-
a
23
H
H
Cl
R12
O
H
Cl
H
H
Phe




6-chloro-1H-indol-3-yl-beta-




D-galactopyranoside


35
I24a
1-(2-Benzoyl-5-methoxy-
a
24
H
H
Cl
R12
O
H
OMe
H
H
Phe




phenyl)-6-chloro-1H-indol-3-




yl-beta-D-galactopyranoside


36
I25a
1-[2-(2,4-Dimethoxy-
a
25
H
H
H
R12
O
H
H
H
H
DMP




benzoyl)phenyl]-1H-indol-3-




yl-beta-D-galactopyranoside


37
I25c
1-[2-(2,4-Dimethoxy--
c
25
H
H
H
R12
O
H
H
H
H
DMP




benzoyl)phenyl]-1H-indol-3-yl




acetate


38
I25d
1-[2-(2,4-Dimethoxy-
d
25
H
H
H
R12
O
H
H
H
H
DMP




benzoyl)phenyl]-1H-indol-3-yl




choline phosphate


39
I26a
1-[2-(2,4-Dimethoxy-
a
26
Cl
H
H
R12
O
H
H
H
H
DMP




benzoyl)phenyl]-4-chloro-1H-




indol-3-yl-beta-D-




galactopyranoside


40
I27a
6-Chloro 1-[2-(2,4-dimethoxy-
a
27
H
H
Cl
R12
O
H
H
H
H
DMP




benzoyl)phenyl]-1H-indol-3-




yl-beta-D-galactopyranoside


41
I28a
5-Bromo-4-chloro-1-[2-(2,4-
a
28
Cl
Br
H
R12
O
H
H
H
H
DMP




dimethoxybenzoyl)phenyl]-




1H-indol-3-yl-beta-D-




galactopyranoside


42
I29a
1-[2-(5-Carboxylfuranoyl)-
a
29
H
H
Cl
R12
O
H
H
H
H
CFur




phenyl]-6-chloro-1H-indol-3-




yl-beta-D-galactopyranoside


43
I30a
6-Chloro-1-(2-furanoyl-
a
30
H
H
Cl
R12
O
H
H
H
H
Fur




phenyl)-1H-indol-3-yl-beta-D-




galactopyranoside


44
I31a
6-Chloro-1-[2-(N-methyl-
a
31
H
H
Cl
R12
O
H
H
H
H
NPyr




pyrrole-2-carbonyl)phenyl]-




1H-indol-3-yl-beta-D-




galactopyranoside


45
I32-
1-(2-Benzoylphenyl)-1H-
1)
32
H
H
H
R12
N
H
H
H
H
Phe




indol-3-yl ethyl carbamate


46
I33-
Bis[1-(2-acetylphenyl)-1H-
2)
33
H
H
H
R12
S
H
H
H
H
Me




indol-3-yl]-disulfane





1) LG: —N—C═O-Ethyl (ethylcarbamate)


2) LG: —S—S— (disulfane) or isothiuronium iodide













TABLE Ib







List of 1H-Indol-3-yl Active Signalogens









Chemical Structure of Active Signalogen




















Entry
Code
Active Signalogen
R1
R2
R3
R4
R5
X
R6
R7
R8
R9
R10























1
aS1
1H-Indol-3-ol
H
H
H
H
H
O







2
aS2
4-Chloro-1H-indol-3-ol
Cl
H
H
H
H
O







3
aS3
6-Chloro-1H-indol-3-ol
H
H
Cl
H
H
O







4
aS4
5-Bromo-4-chloro-1H-indol-3-
Cl
Br
H
H
H
O









ol


5
aS5
5-Bromo-6-chloro-1H-indol-3-
H
Br
Cl
H
H
O









ol


6
aS6
1H-Indol-3-amine
H
H
H
H
H
N







7
aS7
1H-Indol-3-thiol
H
H
H
H
H
S







8
aS8
1-Phenyl-1H-indol-3-ol
H
H
H
H
R11
O
H
H
H
H
H


9
aS9
6-Chloro-1-phenyl-1H-indol-3-
H
H
Cl
H
R11
O
H
H
H
H
H




ol


10
aS10
1-[2-(Methoxy-
H
H
H
H
R12
O
H
H
H
H
OMe




carbonyl)phenyl]-1H-indol-3-ol


11
aS11
1-[2-(Methoxy-
H
H
Cl
H
R12
O
H
H
H
H
OMe




carbonyl)phenyl]-6-chloro-1H-




indol-3-ol


12
aS12
5-Bromo-4-chloro-1-[2-
Cl
Br
H
H
R12
O
H
H
H
H
OMe




(methoxycarbonyl)phenyl)-1H-




indol-3-ol


13
aS13
1-(2-Formylphenyl)-1H-indol-3-
H
H
H
H
R12
O
H
H
H
H
H




ol


14
aS14
1-(2-Acetylphenyl)-1H-indol-3-
H
H
H
H
R12
O
H
H
H
H
Me




ol


15
aS15
1-(2-Acetylphenyl)-4-chloro-
Cl
H
H
H
R12
O
H
H
H
H
Me




1H-indol-3-ol


16
aS16
1-(2-Acetylphenyl)-6-chloro-
H
H
Cl
H
R12
O
H
H
H
H
Me




1H-indol-3-ol


17
aS17
1-(2-Acetylphenyl)-5-bromo-4-
Cl
Br
H
H
R12
O
H
H
H
H
Me




chloro-1H-indol-3-ol


18
aS18
1-(2-Acetyl-5-methoxyphenyl)-
H
H
Cl
H
R12
O
H
OMe
H
H
Me




6-chloro-1H-indol-3-ol


19
aS19
1-(2-Benzoylphenyl)-1H-indol-
H
H
H
H
R12
O
H
H
H
H
Phe




3-ol


20
aS20
1-(2-Benzoylphenyl)-4-chloro-
Cl
H
H
H
R12
O
H
H
H
H
Phe




1H-indol-3-ol


21
aS21
1-(2-Benzoylphenyl)-6-chloro-
H
H
Cl
H
R12
O
H
H
H
H
Phe




1H-indol-3-ol


22
aS22
1-(2-Benzoylphenyl)-5-bromo-
Cl
Br
H
H
R12
O
H
H
H
H
Phe




4-chloro-1H-indol-3-ol


23
aS23
1-(2-Benzoyl-5-chlorphenyl)-6-
H
H
Cl
H
R12
O
H
Cl
H
H
Phe




chloro-1H-indol-3-ol


24
aS24
1-(2-Benzoyl-5-methoxy-
H
H
Cl
H
R12
O
H
OMe
H
H
Phe




phenyl)-6-chloro-1H-indol-3-ol


25
aS25
1-[2-(2,4-Dimethoxy-
H
H
H
H
R12
O
H
H
H
H
DMP




benzoyl)phenyl]-1H-indol-3-ol


26
aS26
4-Chloro-1-[2-(2,4-dimethoxy-
Cl
H
H
H
R12
O
H
H
H
H
DMP




benzoyl)phenyl]-1H-indol-3-ol


27
aS27
6-Chloro-1-[2-(2,4-dimethoxy-
H
H
Cl
H
R12
O
H
H
H
H
DMP




benzoyl)phenyl]-1H-indol-3-ol


28
aS28
5-Bromo-4-chloro-1-[2-(2,4-
Cl
Br
H
H
R12
O
H
H
H
H
DMP




dimethoxybenzoyl)phenyl]-1H-




indol-3-ol


29
aS29
6-Chloro-1-[2-(5-carboxyl-
H
H
Cl
H
R12
O
H
H
H
H
CFur




furanoyl)phenyl]-1H-indol-3-ol


30
aS30
6-Chloro-1-(2-furanoylphenyl)-
H
H
Cl
H
R12
O
H
H
H
H
Fur




1H-indol-3-ol


31
aS31
6-Chloro-1-[2-(N-methyl-
H
H
Cl
H
R12
O
H
H
H
H
NPyr




pyrrole-2-carbonyl)phenyl]-1H-




indol-3-ol


32
aS32
1-(2-Benzoylphenyl)-1H-indol-
H
H
H
H
R12
N
H
H
H
H
Phe




3-amine


33
aS33
1-(2-Acetylphenyl)-1H-indol-3-
H
H
H
H
R12
S
H
H
H
H
Me




thiol
















TABLE Ic







List of Signalophores produced by 1H-indol-3-yl Indicator Systems









Chemical Structure of Signalophore (R13 = R10, OH)























Entry
Code
Type
Signalophore
aS
aR
R1
R2
R3
R4
R5
X
R6
R7
R8
R9
R13


























1
IN1
IN
Indigo
1
Air
H
H
H
H
H
O







2
IN2
IN
4,4′-Dichloroindigo
2
Air
Cl
H
H
H
H
O







3
IN3
IN
6,6′-Dichloroindigo
3
Air
H
H
Cl
H
H
O







4
IN4
IN
5,5′-Dibromo-4,4′-
4
Air
Cl
Br
H
H
H
O










dichloroindigo


5
IN5
IN
5,5′-Dibromo-6,6′-
5
Air
H
Br
Cl
H
H
O










dichloroindigo


6
IN8
IN
1,1′-Diphenylindigo
8
Air
H
H
H
H
R11
O
H
H
H
H
H


7
IN9
IN
6,6′-Dichloro-1,1-
9
Air
H
H
Cl
H
R11
O
H
H
H
H
H





diphenylindigo


8
IN10
IN
1,1′-Di[2-(methoxy-
10
Air
H
H
H
H
R12
O
H
H
H
H
OMe





carbonyl)phenyl]indigo


9
IN11
IN
1,1′-Di[2-(methoxy-
11
Air
H
H
Cl
H
R12
O
H
H
H
H
OMe





carbonyl)phenyl]-6,6′-





dichloroindigo


10
IN12
IN
1,1′-Di[2-(methoxy-
12
Air
Cl
Br
H
H
R12
O
H
H
H
H
OMe





carbonyl)phenyl]-5,5′-





dibromo-4,4′-





dichloroindigo


11
BI1
BI
2-(4-Dimethylamino-2-
1
MDAB
H
H
H
H
H
O










methoxybenzylidene)indolin-





3-one


12
BI2
BI
4-Chloro-2-(4-
2
MDAB
Cl
H
H
H
H
O










dimethylamino-2-





methoxybenzylidene)indolin-





3-one


13
BI3
BI
6-Chloro-2-(4-
3
MDAB
H
H
Cl
H
H
O










dimethylamino-2-





methoxybenzylidene)indolin-





3-one


14
BI4
BI
5-Bromo-4-chloro-2-
4
MDAB
Cl
Br
H
H
H
O










(4-dimethylamino-2-





methoxybenzylidene)indolin-





3-one


15
BI5
BI
5-Bromo-6-chloro-2-
5
MDAB
H
Br
Cl
H
H
O










(4-dimethylamino-2-





methoxybenzylidene)indolin-





3-one


16
BI8
BI
2-(4-Dimethylamino-2-
8
MDAB
H
H
H
H
R11
O
H
H
H
H
H





methoxybenzylidene)-





1-phenylindolin-3-one


17
BI9
BI
6-Chloro-2-(4-
9
MDAB
H
H
Cl
H
R11
O
H
H
H
H
H





dimethylamino-2-





methoxybenzylidene)-





1-phenylindolin-3-one


18
BI10
BI
2-(4-Dimethylamino-2-
10
MDAB
H
H
H
H
R12
O
H
H
H
H
OMe





methoxybenzylidene)-





1-(2-(methoxycarbonyl)phenyl)indolin-





3-





one


19
BI11
BI
6-Chloro-2-(4-
11
MDAB
H
H
Cl
H
R12
O
H
H
H
H
OMe





dimethylamino-2-





methoxybenzylidene)-





1-[2-(methoxy-





carbonyl)-





phenyl]indolin-3-one


20
BI12
BI
5-Bromo-4-chloro-2-
12
MDAB
Cl
Br
H
H
R12
O
H
H
H
H
OMe





(4-dimethylamino-2-





methoxybenzylidene)-





1-[2-(methoxy-





carbonyl)-





phenyl]indolin-3-one


21
BI6
BI
2-(4-Dimethylamino-2-
6
MDAB
H
H
H
H
H
N










methoxybenzylidene)indolin-





3-imine


22
BI7
BI
2-(4-Dimethylamino-2-
7
MDAB
H
H
H
H
H
S










methoxybenzylidene)indolin-





3-thione


23
IO10
IO
11-Hydroxy-10H-indolo[1,
10

H
H
H
H
NA
O
H
H
H
H
OH





2-a]indol-10-one


24
IO11
IO
7-Chloro-11-hydroxy-
11

H
H
Cl
H
NA
O
H
H
H
H
OH





10H-indolo[1,2-a]indol-





10-one


25
IO12
IO
8-Bromo-9-chloro-11-
12

Cl
Br
H
H
NA
O
H
H
H
H
OH





hydroxy-10H-indolo-





[1,2-a]indol-10-one


26
IO13
IO
10H-Indolo[1,2-a]indol-
13

H
H
H
H
NA
O
H
H
H
H
H





10-one


27
IO14
IO
11-Methyl-10H-indolo-
14

H
H
H
H
NA
O
H
H
H
H
Me





[1,2-a]indol-10-one


28
IO15
IO
9-Chloro-11-methyl-
15

Cl
H
H
H
NA
O
H
H
H
H
Me





10H-indolo[1,2-a]indol-





10-one


29
IO16
IO
7-Chloro-11-methyl-
16

H
H
Cl
H
NA
O
H
H
H
H
Me





10H-indolo[1,2-a]indol-





10-one


30
IO17
IO
8-Bromo-9-chloro-11-
17

Cl
Br
H
H
NA
O
H
H
H
H
Me





methyl-10H-indolo[1,2-





a]indol-10-one


31
IO18
IO
7-Chloro-11-methyl-3-
18

H
H
Cl
H
NA
O
H
OMe
H
H
Me





methoxy-10H-indolo-





[1,2-a]indol-10-one


32
IO19
IO
11-Phenyl-10H-indolo-
19

H
H
H
H
NA
O
H
H
H
H
Phe





[1,2-a]indol-10-one


33
IO20
IO
9-Chloro-11-phenyl-
20

Cl
H
H
H
NA
O
H
H
H
H
Phe





10H-indolo[1,2-a]indol-





10-one


34
IO21
IO
7-Chloro-11-phenyl-
21

H
H
Cl
H
NA
O
H
H
H
H
Phe





10H-indolo[1,2-a]indol-





10-one


35
IO22
IO
8-Bromo-9-chloro-11-
22

Cl
Br
H
H
NA
O
H
H
H
H
Phe





phenyl-10H-indolo[1,2-





a]indol-10-one


36
IO23
IO
3,7-Dichloro-11-
23

H
H
Cl
H
NA
O
H
Cl
H
H
Phe





phenyl-10H-indolo[1,2-





a]indol-10-one


37
IO24
IO
7-Chloro-3-methoxy-
24

H
H
Cl
H
NA
O
H
OMe
H
H
Phe





11-phenyl-10H-indolo-





[1,2-a]indol-10-one


38
IO25
IO
11-(2,4-Dimethoxy)-
25

H
H
H
H
NA
O
H
H
H
H
DMP





phenyl-10H-indolo[1,2-





a]indol-10-one


39
IO27
IO
7-Chloro-11-(2,4-
27

H
H
Cl
H
NA
O
H
H
H
H
DMP





dimethoxy)phenyl-





10H-indolo[1,2-a]indol-





10-one


40
IO26
IO
9-Chloro-11-(2,4-
26

Cl
H
H
H
NA
O
H
H
H
H
DMP





dimethoxy)phenyl-





10H-indolo[1,2-a]indol-





10-one


41
IO28
IO
8-Bromo-9-chloro-11-
28

Cl
Br
H
H
NA
O
H
H
H
H
DMP





(2,4-dimethoxy)phenyl-





10H-indolo[1,2-





a]indol-10-one


42
IO29
IO
7-Chloro-11-(5-
29

H
H
Cl
H
NA
O
H
H
H
H
CFur





carboxyfuran-2-yl)-





10H-indolo[1,2-a]indol-





10-one


43
IO30
IO
7-Chloro-11-(furan-2-
30

H
H
Cl
H
NA
O
H
H
H
H
Fur





yl)-10H-indolo[1,2-





a]indol-10-one


44
IO32
IO
11-Phenyl-10H-
32

H
H
H
H
NA
N
H
H
H
H
Phe





indolo[1,2-a]indol-10-





imine


45
IO33
IO
11-Metyl-10H-indolo-
33

H
H
H
H
NA
S
H
H
H
H
Me





[1,2-a]indol-10-thione


46
IO31
IO
7-Chloro-11-(N-
31

H
H
Cl
H
NA
O
H
H
H
H
NPyr





methylpyrrol-2-yl)-





10H-indolo[1,2-a]indol-





10-one
















TABLE IIa







List of Aerobic 1H-Indol-3-yl Indicator Systems (no MDAB)









Signalophore
















Entry
Indicator/Active Signalogen
Code
aS
aR
LG
External Stimulus
BI
IO
IN



















1
1H-Indol-3-yl-beta-D-
I1a
1
Air
a
Enzyme: beta-D-
NA
NA
1



galactopyranoside




galactosidase


2
1H-Indol-3-yl acetate
I1c
1
Air
c
Enzyme: Esterase; Ion:
NA
NA
1








Hydroxide


3
4-Chloro-1H-indol-3-yl-beta-
I2a
2
Air
a
Enzyme: beta-D-
NA
NA
2



D-galactopyranoside




galactosidase


4
6-Chloro-1H-indol-3-yl-beta-
I3a
3
Air
a
Enzyme: beta-D-
NA
NA
3



D-galactopyranoside




galactosidase


5
6-Chloro-1H-indol-3-yl-alpha-
I3e
3
Air
e
Enzyme: alpha-
NA
NA
3



D-glucopyranoside




glucosidase


6
6-Chloro-1H-indol-3-yl-beta-
I3f
3
Air
f
Enzyme: beta-D-
NA
NA
3



D-glucuronide sodium salt




glucuronidase


7
6-Chloro-1H-indol-3-yl-N-
I3g
3
Air
g
Enzyme: Galactosamidase
NA
NA
3



acetyl-beta-D-



galactosaminide


8
5-Bromo-4-chloro-1H-indol-3-
I4a
4
Air
a
Enzyme: beta-D-
NA
NA
4



yl-beta-D-galactopyranoside




galactosidase


9
5-Bromo-3-(tert-
I4b
4
Air
b
Ion: Fluoride
NA
NA
4



butyldimethylsilyloxy)-4-



chloro-1H-indole


10
5-Bromo-4-chloro-1H-indol-3-
I4c
4
Air
c
Enzyme: Esterase; Ion:
NA
NA
4



yl acetate




Hydroxide


11
5-Bromo-4-chloro-1H-indol-3-
I4d
4
Air
d
Enzyme: Phospholipase c
NA
NA
4



yl choline phosphate


12
5-Bromo-4-chloro-1H-indol-3-
I4h
4
Air
h
Enzyme: beta-D-
NA
NA
4



yl-beta-D-glucopyranoside




glucosidase


13
5-Bromo-6-chloro-1H-indol-3-
I5a
5
Air
a
Enzyme: beta-D-
NA
NA
4



yl-beta-D-galactopyranoside




galactosidase


14
1H-Indol-3-yl-ethyl carbamate
I6
6
Air
1)
Enzyme: Esterase; Ion:
NA
NA
*








Hydroxide


15
(1H-Indol-3-thiol)
NA
7
Air
2)

NA
NA



16
1-Phenyl-1H-indol-3-yl-beta-
I8a
8
Air
a
Enzyme: beta-D-
NA
NA
8



D-galactopyranoside




galactosidase


17
6-Chloro-1-phenyl-1H-indol-
I9a
9
Air
a
Enzyme: beta-D-
NA
NA
9



3-yl-beta-D-




galactosidase



galactopyranoside


18
1-[2-(Methoxy-
I10a
10
Air
a
Enzyme: beta-D-
NA
10
(10) 



carbonyl)phenyl]-1H-indol-3-




galactosidase



yl-beta-D-galactopyranoside


19
6-Chloro-1-[2-(methoxy-
I11a
11
Air
a
Enzyme: beta-D-
NA
11
(11) 



carbonyl)phenyl]-1H-indol-3-




galactosidase



yl-beta-D-galactopyranoside


20
5-Bromo-4-chloro-1-[2-
I12a
12
Air
a
Enzyme: beta-D-
NA
12
(12) 



(methoxycarbonyl)phenyl]-




galactosidase



1H-indol-3-yl-beta-D-



galactopyranoside


21
1-(2-Formylphenyl)-1H-indol-
I13a
13
Air
a
Enzyme: beta-D-
NA
13




3-yl-beta-D-




galactosidase



galactopyranoside


22
1-(2-Acetylphenyl)-1H-indol-
I14a
14
Air
a
Enzyme: beta-D-
NA
14




3-yl-beta-D-




galactosidase



galactopyranoside


23
1-(2-Acetylphenyl)-4-chloro-
I15a
15
Air
a
Enzyme: beta-D-
NA
15




1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


24
1-(2-Acetylphenyl)-6-chloro-
I16a
16
Air
a
Enzyme: beta-D-
NA
16




1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


25
1-(2-Acetylphenyl)-5-bromo-
I17a
17
Air
a
Enzyme: beta-D-
NA
17




4-chloro-1H-indol-3-yl-beta-




galactosidase



D-galactopyranoside


26
1-(2-Acetyl-5-
I18a
18
Air
a
Enzyme: beta-D-
NA
18




methoxyphenyl)-6-chloro-1H-




galactosidase



indol-3-yl-beta-D-



galactopyranoside


27
1-(2-Benzoylphenyl)-1H-
I19a
19
Air
a
Enzyme: beta-D-
NA
19




indol-3-yl-beta-D-




galactosidase



galactopyranoside


28
1-(2-Benzoylphenyl)-1H-
I19c
19
Air
c
Enzyme: Esterase; Ion:
NA
19




indol-3-yl acetate




Hydroxide


29
1-(2-Benzoylphenyl)-4-
I20a
20
Air
a
Enzyme: beta-D-
NA
20




chloro-1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


30
1-(2-Benzoylphenyl)-6-
I21a
21
Air
a
Enzyme: beta-D-
NA
21




chloro-1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


31
1-(2-Benzoylphenyl)-6-
I21e
21
Air
e
Enzyme: alpha-
NA
21




chloro-1H-indol-3-yl-alpha-D-




glucosidase



glucopyranoside


32
1-(2-Benzoylphenyl)-6-
I21f
21
Air
f
Enzyme: beta-D-
NA
21




chloro-1H-indol-3-yl-beta-D-




glucuronidase



glucuronide sodium salt


33
1-(2-Benzoylphenyl)-6-
I21g
21
Air
g
Enzyme: Galactosamidase
NA
21




chloro-1H-indol-3-yl-N-acetyl-



beta-D-galactosaminide


34
1-(2-Benzoylphenyl)-5-
I22a
22
Air
a
Enzyme: beta-D-
NA
22




bromo-4-chloro-1H-indol-3-yl-




galactosidase



beta-D-galactopyranoside


35
1-(2-Benzoyl-5-chlorphenyl)-
I23a
23
Air
a
Enzyme: beta-D-
NA
23




6-chloro-1H-indol-3-yl-beta-




galactosidase



D-galactopyranoside


36
1-(2-Benzoyl-5-methoxy-
I24a
24
Air
a
Enzyme: beta-D-
NA
24




phenyl)-6-chloro-1H-indol-3-




galactosidase



yl-beta-D-galactopyranoside


37
1-[2-(2,4-Dimethoxy-
I25a
25
Air
a
Enzyme: beta-D-
NA
25




benzoyl)lphenyl]-1H-indol-3-




galactosidase



yl-beta-D-galactopyranoside


38
1-[2-(2,4-Dimethoxy-
I25c
25
Air
c
Enzyme: Esterase; Ion:
NA
25




benzoyl)phenyl]-1H-indol-3-yl




Hydroxide



acetate


39
1-[2-(2,4-Dimethoxy-
I25d
25
Air
d
Enzyme: Phospholipase c
NA
25




benzoyl)phenyl]-1H-indol-3-yl



choline phosphate


40
6-Chloro-1-[2-(2,4-dimethoxy-
I27a
26
Air
a
Enzyme: beta-D-
NA
26




benzoyl)phenyl]-1H-indol-3-




galactosidase



yl-beta-D-galactopyranoside


41
4-Chloro-1-[2-(2,4-dimethoxy-
I26a
27
Air
a
Enzyme: beta-D-
NA
27




benzoyl)phenyl]-1H-indol-3-




galactosidase



yl-beta-D-galactopyranoside


42
5-Bromo-4-chloro-1-[2-(2,4-
I28a
28
Air
a
Enzyme: beta-D-
NA
28




dimethoxybenzoyl)phenyl]-




galactosidase



1H-indol-3-yl-beta-D-



galactopyranoside


43
1-[2-(5-Carboxyl-
I29a
29
Air
a
Enzyme: beta-D-
NA
29




furanoyl)phenyl]-6-chloro-1H-




galactosidase



indol-3-yl-beta-D-



galactopyranoside


44
6-Chloro-1-(2-furanoyl-
I30a
30
Air
a
Enzyme: beta-D-
NA
30




phenyl)-1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


45
6-Chloro-1-[2-(N-methyl-
I31a
31
Air
a
Enzyme: beta-D-
NA
31




pyrrole-2-carbonyl)phenyl]-




galactosidase



1H-indol-3-yl-beta-D-



galactopyranoside


46
1-(2-Benzoylphenyl)-1H-
I32
32
Air
1)
Enzyme: Esterase; Ion:
NA
32




indol-3-yl ethyl carbamate




Hydroxide


47
Bis[1-(2-acetylphenyl)-1H-
I33
33
Air
2)
Reducing Agent: TCEP
NA
33




indol-3-yl]-disulfane





NP: Not Performed


NA: Not Applicable


*: dark precipitate


1) LG: —N—C═O-Ethyl (ethylcarbamate)


2) LG: —S—S-(disulfane) or isothiuronium iodide













TABLE IIb







List of Aerobic 1H-Indol-3-yl/MDAB Indicator Systems









Signalophore
















Entry
Indicator/Active Signalogen
Code
aS
aR
LG
External Stimulus
BI
IO
IN



















1
1H-Indol-3-yl-beta-D-
I1a
1
Air/MDAB
a
Enzyme: beta-D-
(1)
NA
1



galactopyranoside




galactosidase


2
1H-Indol-3-yl acetate
I1c
1
Air/MDAB
c
Enzyme: Esterase;
NP
NA
NP








Ion: Hydroxide


3
4-Chloro-1H-indol-3-yl-beta-
I2a
2
Air/MDAB
a
Enzyme: beta-D-
(2)
NA
2



D-galactopyranoside




galactosidase


4
6-Chloro-1H-indol-3-yl-beta-
I3a
3
Air/MDAB
a
Enzyme: beta-D-
(3)
NA
3



D-galactopyranoside




galactosidase


5
6-Chloro-1H-indol-3-yl-alpha-
I3e
3
Air/MDAB
e
Enzyme: alpha-
NP
NA
NP



D-glucopyranoside




glucosidase


6
6-Chloro-1H-indol-3-yl-beta-
I3f
3
Air/MDAB
f
Enzyme: beta-D-
NP
NA
NP



D-glucuronide sodium salt




glucuronidase


7
6-Chloro-1H-indol-3-yl-N-
I3g
3
Air/MDAB
g
Enzyme: Galactosamidase
NP
NA
NP



acetyl-beta-D-



galactosaminide


8
5-Bromo-4-chloro-1H-indol-3-
I4a
4
Air/MDAB
a
Enzyme: beta-D-
(4)
NA
4



yl-beta-D-galactopyranoside




galactosidase


9
5-Bromo-3-(tert-
I4b
4
Air/MDAB
b
Ion: Fluoride
(4)
NA
4



butyldimethylsilyloxy)-4-



chloro-1H-indole


10
5-Bromo-4-chloro-1H-indol-3-
I4c
4
Air/MDAB
c
Enzyme: Esterase;
(4)
NA
4



yl acetate




Ion: Hydroxide


11
5-Bromo-4-chloro-1H-indol-3-
I4d
4
Air/MDAB
d
Enzyme: Phospholipase c
NP
NP
NP



yl choline phosphate


12
5-Bromo-4-chloro-1H-indol-3-
I4h
4
Air/MDAB
h
Enzyme: beta-D-
NP
NP
NP



yl-beta-D-glucopyranoside




glucosidase


13
5-Bromo-6-chloro-1H-indol-3-
I5a
5
Air/MDAB
a
Enzyme: beta-D-
(4)
NA
4



yl-beta-D-galactopyranoside




galactosidase


14
1H-Indol-3-yl-ethyl carbamate
I6
6
Air/MDAB
1)
Enzyme: Esterase;
*
NA









Ion: Hydroxide


15
(1H-Indol-3-thiol)
NA
7
Air/MDAB
2)
Ion: Hydroxyde
(6)
NA



16
1-Phenyl-1H-indol-3-yl-beta-
I8a
8
Air/MDAB
a
Enzyme: beta-D-
NP
NP
NP



D-galactopyranoside




galactosidase


17
6-Chloro-1-phenyl-1H-indol-3-
I9a
9
Air/MDAB
a
Enzyme: beta-D-
9
NA
(9)



yl-beta-D-galactopyranoside




galactosidase


18
1-[2-(Methoxy-
I10a
10
Air/MDAB
a
Enzyme: beta-D-

10




carbonyl)phenyl]-1H-indol-3-




galactosidase



yl-beta-D-galactopyranoside


19
6-Chloro-1-[2-(methoxy-
I11a
11
Air/MDAB
a
Enzyme: beta-D-
11 
(10)




carbonyl)phenyl]-1H-indol-3-




galactosidase



yl-beta-D-galactopyranoside


20
5-Bromo-4-chloro-1-[2-
I12a
12
Air/MDAB
a
Enzyme: beta-D-

12
(12) 



(methoxycarbonyl)phenyl]-1H-




galactosidase



indol-3-yl-beta-D-



galactopyranoside


21
1-(2-Formylphenyl)-1H-indol-
I13a
13
Air/MDAB
a
Enzyme: beta-D-

13
(13) 



3-yl-beta-D-galactopyranoside




galactosidase


22
1-(2-Acetylphenyl)-1H-indol-3-
I14a
14
Air/MDAB
a
Enzyme: beta-D-

14




yl-beta-D-galactopyranoside




galactosidase


23
1-(2-Acetylphenyl)-4-chloro-
I15a
15
Air/MDAB
a
Enzyme: beta-D-

15




1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


24
1-(2-Acetylphenyl)-6-chloro-
I16a
16
Air/MDAB
a
Enzyme: beta-D-

16




1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


25
1-(2-Acetylphenyl)-5-bromo-4-
I17a
17
Air/MDAB
a
Enzyme: beta-D-

17




chloro-1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


26
1-(2-Acetyl-5-methoxy-
I18a
18
Air/MDAB
a
Enzyme: beta-D-

18




phenyl)-6-chloro-1H-indol-3-




galactosidase



yl-beta-D-galactopyranoside


27
1-(2-Benzoylphenyl)-1H-indol-
I19a
19
Air/MDAB
a
Enzyme: beta-D-

19




3-yl-beta-D-galactopyranoside




galactosidase


28
1-(2-Benzoylphenyl)-1H-indol-
I19c
19
Air/MDAB
c
Enzyme: Esterase;
NP
NP
NP



3-yl acetate




Ion: Hydroxide


29
1-(2-Benzoylphenyl)-4-chloro-
I20a
20
Air/MDAB
a
Enzyme: beta-D-

20




1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


30
1-(2-Benzoylphenyl)-6-chloro-
I21a
21
Air/MDAB
a
Enzyme: beta-D-

21




1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


31
1-(2-Benzoylphenyl)-6-chloro-
I21e
21
Air/MDAB
e
Enzyme: alpha-
NP
NP
NP



1H-indol-3-yl-alpha-D-




glucosidase



glucopyranoside


32
1-(2-Benzoylphenyl)-6-chloro-
I21f
21
Air/MDAB
f
Enzyme: beta-D-
NP
NP
NP



1H-indol-3-yl-beta-D-




glucuronidase



glucuronide sodium salt


33
1-(2-Benzoylphenyl)-6-chloro-
I21g
21
Air/MDAB
g
Enzyme: Galactosamidase
NP
NP
NP



1H-indol-3-yl-N-acetyl-beta-D-



galactosaminide


34
1-(2-Benzoylphenyl)-5-bromo-
I22a
22
Air/MDAB
a
Enzyme: beta-D-

22




4-chloro-1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


35
1-(2-Benzoyl-5-chlorophenyl)-
I23a
23
Air/MDAB
a
Enzyme: beta-D-

23




6-chloro-1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


36
1-(2-Benzoyl-5-methoxy-
I24a
24
Air/MDAB
a
Enzyme: beta-D-

24




phenyl)-6-chloro-1H-indol-3-




galactosidase



yl-beta-D-galactopyranoside


37
1-[2-(2,4-Dimethoxy-
I25a
25
Air/MDAB
a
Enzyme: beta-D-

25




benzoyl)phenyl]-1H-indol-3-yl-




galactosidase



beta-D-galactopyranoside


38
1-[2-(2,4-Dimethoxy-
I25c
25
Air/MDAB
c
Enzyme: Esterase;
NP
NP
NP



benzoyl)phenyl]-1H-indol-3-yl




Ion: Hydroxide



acetate


39
1-[2-(2,4-Dimethoxy-
I25d
25
Air/MDAB
d
Enzyme: Phospholipase c
NP
NP
NP



benzoyl)phenyl]-1H-indol-3-yl



choline phosphate


40
1-[2-(2,4-Dimethoxy-
I27a
27
Air/MDAB
a
Enzyme: beta-D-

27




benzoyl)phenyl]-6-chloro-1H-




galactosidase



indol-3-yl-beta-D-



galactopyranoside


41
1-[2-(2,4-Dimethoxy-
I26a
26
Air/MDAB
a
Enzyme: beta-D-

26




benzoyl)phenyl]-4-chloro-1H-




galactosidase



indol-3-yl-beta-D-



galactopyranoside


42
5-Bromo-4-chloro-1-[2-(2,4-
I28a
28
Air/MDAB
a
Enzyme: beta-D-

28




dimethoxybenzoyl)phenyl]-




galactosidase



1H-indol-3-yl-beta-D-



galactopyranoside


43
6-Chloro-1-[2-(5-carboxyl-
I29a
29
Air/MDAB
a
Enzyme: beta-D-

29




furanoyl)phenyl)-1H-indol-3-




galactosidase



yl-beta-D-galactopyranoside


44
6-Chloro-1-(2-furanoyl-
I30a
30
Air/MDAB
a
Enzyme: beta-D-

30




phenyl)-1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


45
6-Chloro-1-[2-(N-methyl-
I31a
31
Air/MDAB
a
Enzyme: beta-D-
NP
NP
NP



pyrrole-2-carbonyl)phenyl]-




galactosidase



1H-indol-3-yl-beta-D-



galactopyranoside


46
1-(2-Benzoylphenyl)-1H-indol-
I32
32
Air/MDAB
1)
Enzyme: Esterase;
NP
NP
NP



3-yl ethyl carbamate




Ion: Hydroxide


47
Bis(1-(2-acetylphenyl)-1H-
I33
33
Air/MDAB
2)
Reducing Agent:
NP
NP
NP



indol-3-yl]-disulfane




TCEP





NP: Not Performed


NA: Not Applicable


*: yellow-brown solution


1) LG: —N—C═O-Ethyl (ethylcarbamate)


2) LG: —S—S-(disulfane) or isothiuronium iodide













TABLE IIc







List of Anaerobic 1H-Indol-3-yl/MDAB Indicator Systems









Signalophore
















Entry
Indicator/(active Signalogen)
Code
aS
aR
LG
External Stimulus
BI
IO
IN



















1
1H-Indol-3-yl-beta-D-
I1a
1
MDAB
a
Enzyme: beta-D-
1
NA




galactopyranoside




galactosidase


2
1H-Indol-3-yl acetate
I1c
1
MDAB
c
Enzyme: Esterase;
1
NA









Ion: Hydroxide


3
4-Chloro-1H-indol-3-yl-beta-D-
I2a
2
MDAB
a
Enzyme: beta-D-
2
NA




galactopyranoside




galactosidase


4
6-Chloro-1H-indol-3-yl-beta-D-
I3a
3
MDAB
a
Enzyme: beta-D-
3
NA




galactopyranoside




galactosidase


5
6-Chloro-1H-indol-3-yl-alpha-D-
I3e
3
MDAB
e
Enzyme: alpha-
NP
NP
NP



glucopyranoside




glucosidase


6
6-Chloro-1H-indol-3-yl-beta-D-
I3f
3
MDAB
f
Enzyme: beta-D-
NP
NP
NP



glucuronide sodium salt




glucuronidase


7
6-Chloro-1H-indol-3-yl-N-acetyl-
I3g
3
Air/MDAB
g
Enzyme: Galacto-
NP
NP
NP



beta-D-galactosaminide




samidase


8
5-Bromo-4-chloro-1H-indol-3-yl-
I4a
4
MDAB
a
Enzyme: beta-D-
4
NA




beta-D-galactopyranoside




galactosidase


9
5-Bromo-3-(tert-butyldimethyl-
I4b
4
MDAB
b
Ion: Fluoride
4
NA




silyloxy)-4-chloro-1H-indole


10
5-Bromo-4-chloro-1H-indol-3-yl
I4c
4
MDAB
c
Enzyme: Esterase
4
NA




acetate


11
5-Bromo-4-chloro-1H-indol-3-yl
I4d
4
MDAB
d
Enzyme: Phospholipase c
NP
NP
NP



choline phosphate


12
5-Bromo-4-chloro-1H-indol-3-yl-
I4h
4
Air/MDAB
h
Enzyme: beta-D-
NP
NP
NP



beta-D-glucopyranoside




glucosidase


13
5-Bromo-6-chloro-1H-indol-3-yl-
I5a
5
MDAB
a
Enzyme: beta-D-
4
NA




beta-D-galactopyranoside




galactosidase


14
1H-Indol-3-yl-ethyl carbamate
I6
6
MDAB



NA
*


15
(1H-Indol-3-thiol)
NA
7
MDAB


6
NA



16
1-Phenyl-1H-indol-3-yl-beta-D-
I8a
8
MDAB
a
Enzyme: beta-D-
NP
NP
NP



galactopyranoside




galactosidase


17
6-Chloro-1-phenyl-1H-indol-3-yl-
I9a
9
MDAB
a
Enzyme: beta-D-
9
NA




beta-D-galactopyranoside




galactosidase


18
1-[2-(Methoxycarbonyl)phenyl]-
I10a
10
MDAB
a
Enzyme: beta-D-

10




1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


19
6-Chloro-1-[2-(methoxy-
I11a
11
MDAB
a
Enzyme: beta-D-
11 
11




carbonyl)phenyl]-1H-indol-3-yl-




galactosidase



beta-D-galactopyranoside


20
5-Bromo-4-chloro-1-[2-(methoxy-
I12a
12
MDAB
a
Enzyme: beta-D-

12




carbonyl)phenyl]-1H-indol-3-yl-




galactosidase



beta-D-galactopyranoside


21
1-(2-Formylphenyl)-1H-indol-3-yl-
I13a
13
MDAB
a
Enzyme: beta-D-

13




beta-D-galactopyranoside




galactosidase


22
1-(2-Acetylphenyl)-1H-indol-3-yl-
I14a
14
MDAB
a
Enzyme: beta-D-

14




beta-D-galactopyranoside




galactosidase


23
1-(2-Acetylphenyl)-4-chloro-1H-
I15a
15
MDAB
a
Enzyme: beta-D-

15




indol-3-yl-beta-D-




galactosidase



galactopyranoside


24
1-(2-Acetylphenyl)-6-chloro-1H-
I16a
16
MDAB
a
Enzyme: beta-D-

16




indol-3-yl-beta-D-




galactosidase



galactopyranoside


25
1-(2-Acetylphenyl)-5-bromo-4-
I17a
17
MDAB
a
Enzyme: beta-D-

17




chloro-1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


26
1-(2-Acetyl-5-methoxyphenyl)-6-
I18a
18
MDAB
a
Enzyme: beta-D-

18




chloro-1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


27
1-(2-Benzoylphenyl)-1H-indol-3-
I19a
19
MDAB
a
Enzyme: beta-D-

19




yl-beta-D-galactopyranoside




galactosidase


28
1-(2-Benzoylphenyl)-1H-indol-3-yl
I19c
19
MDAB
c
Enzyme: Esterase
NP
NP
NP



acetate


29
1-(2-Benzoylphenyl)-4-chloro-1H-
I20a
20
MDAB
a
Enzyme: beta-D-

20




indol-3-yl-beta-D-




galactosidase



galactopyranoside


30
1-(2-Benzoylphenyl)-6-chloro-1H-
I21a
21
MDAB
a
Enzyme: beta-D-

21




indol-3-yl-beta-D-




galactosidase



galactopyranoside


31
1-(2-Benzoylphenyl)-6-chloro-1H-
I21e
21
MDAB
e
Enzyme: alpha-
NP
NP
NP



indol-3-yl-alpha-D-




glucosidase



glucopyranoside


32
1-(2-Benzoylphenyl)-6-chloro-1H-
I21f
21
MDAB
f
Enzyme: beta-D-
NP
NP
NP



indol-3-yl-beta-D-glucuronide




glucuronidase



sodium salt


33
1-(2-Benzoylphenyl)-6-chloro-1H-
I21g
21
MDAB
g
Enzyme: Galacto-
NP
NP
NP



indol-3-yl-N-acetyl-beta-D-




samidase



galactosaminide


34
1-(2-Benzoylphenyl)-5-bromo-4-
I22a
22
MDAB
a
Enzyme: beta-D-

22




chloro-1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


35
1-(2-Benzoyl-5-chlorophenyl)-6-
I23a
23
MDAB
a
Enzyme: beta-D-

23




chloro-1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


36
1-(2-Benzoyl-5-methoxyphenyl)-
I24a
24
MDAB
a
Enzyme: beta-D-

24




6-chloro-1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


37
1-[2-(2,4-Dimethoxy-
I25a
25
MDAB
a
Enzyme: beta-D

25




benzoyl)lphenyl]-1H-indol-3-yl-




galactosidase



beta-D-galactopyranoside


38
1-[2-(2,4-Dimethoxy-
I25c
25
MDAB
c
Enzyme: Esterase
NP
NP
NP



benzoyl)phenyl]-1H-indol-3-yl



acetate


39
1-[2-(2,4-Dimethoxy-
I25d
25
MDAB
d
Enzyme: Phospholipase c
NP
NP
NP



benzoyl)phenyl]-1H-indol-3-yl



choline phosphate


40
1-[2-(2,4-Dimethoxy-
I27a
27
MDAB
a
Enzyme: beta-D-

27




benzoyl)phenyl]-6-chloro-1H-




galactosidase



indol-3-yl-beta-D-



galactopyranoside


41
1-[2-(2,4-Dimethoxy-
I26a
26
MDAB
a
Enzyme: beta-D-

26




benzoyl)phenyl]-4-chloro-1H-




galactosidase



indol-3-yl-beta-D-



galactopyranoside


42
1-[2-(2,4-Dimethoxy-
I28a
28
MDAB
a
Enzyme: beta-D-

28




benzoyl)phenyl]-5-bromo-4-




galactosidase



chloro-1H-indol-3-yl-beta-D-



galactopyranoside


43
1-[2-(5-Carboxylfuranoyl)phenyl]-
I29a
29
MDAB
a
Enzyme: beta-D-

29




6-chloro-1H-indol-3-yl-beta-D-




galactosidase



galactopyranoside


44
6-Chloro-1-(2-furanoylphenyl)-1H-
I30a
30
MDAB
a
Enzyme: beta-D-

30




indol-3-yl-beta-D-




galactosidase



galactopyranoside


45
6-Chloro-1-[2-(N-methylpyrrole-2-
I31a
31
MDAB
a
Enzyme: beta-D-
NP
NP
NP



carbonyl)phenyl]-1H-indol-3-yl-




galactosidase



beta-D-galactopyranoside


46
1-(2-Benzoylphenyl)-1H-indol-3-yl
I32
32
MDAB

Enzyme: Esterase
NP
NP
NP



ethyl carbamate


47
Bis(1-(2-acetylphenyl)-1H-indol-3-
I33
33
MDAB

Reducing Agent:
NP
NP
NP



yl]-disulfane




TCEP





NP: Not Performed


NA: Not Applicable


*: yellow-brown solution


1) LG: —N—C═O-Ethyl (ethylcarbamate)


2) LG: —S—S-(disulfane) or isothiuronium iodide













TABLE III







2-Benzylideneindoline (MDAB) staining of colonies of beta-D-galactosidase positive/negative bacteria





















microaerobic (anaerobic)


Entry
Indicator
aR
Equivalents
Species
eS
aerobic conditions
conditions






















b-gal
TSAYE with 40 mg/100 ml
TSAYE with 40 mg/100 ml








of indicator
of indicator


1
I4a

NA

Citrobacter

+
Blue green (dark colored
Green (light colored colonies)







freundii


colonies) with no ring
with no ring


2
I4a
DAB
2:1

Citrobacter

+
Blue green (medium colored
Cream colored colonies







freundii


colonies) with no ring
with no ring


3
I4a
DAB
1:1

Citrobacter

+
Blue green (light colored
Cream colored colonies







freundii


colonies) with clear ring
with no ring


4
I4a
MDAB
2:1

Citrobacter

+
Blue green (dark colored
Green (light colored colonies)







freundii


colonies) with light ring
with no ring


5
I4a
MDAB
1:1

Citrobacter

+
Blue green (light colored
Pink (light colored colonies)







freundii


colonies) with pale red hue
with no ring


6
I4a

NA

Escherichia coli

+
Blue green (very dark
Green (light colored colonies)








colored colonies) with no
with no ring








ring


7
I4a
DAB
2:1

Escherichia coli

+
Blue green (very dark
Pale green (very light








colored colonies) with no
colored colonies) with no








ring
ring


8
I4a
DAB
1:1

Escherichia coli

+
Blue green (very dark
Cream colored colonies








colored colonies) with no
with no ring








ring


9
I4a
MDAB
2:1

Escherichia coli

+
Blue green (very dark
Green (light colored colonies)








colored colonies) with no
with cream ring








ring


10
I4a
MDAB
1:1

Escherichia coli

+
Blue green (very dark
Pink (medium colored








colored colonies) with white
colonies) with cream ring








ring


11
I4a
MDAB
1:1

Salmonella


Cream colored colonies
Cream colored colonies







manhattan



12
I4a
MDAB
1:1

Salmonella


Cream colored colonies
Cream colored colonies







manhattan



13
I5a

NA

Citrobacter

+
Violet (dark colored colonies)
Pale violet (light colored







freundii


with a clear ring
colonies) with no ring


14
I5a
DAB
2:1

Citrobacter

+
Violet (medium colored
Cream colored colonies







freundii


colonies) with a clear ring
with no ring


15
I5a
DAB
1:1

Citrobacter

+
Violet (light medium colored
Cream colored colonies







freundii


colonies) with a white ring
with no ring


16
I5a
MDAB
2:1

Citrobacter

+
Violet (dark colored colonies)
Violet (light colored colonies)







freundii


with a clear ring
with a clear ring


17
I5a
MDAB
1:1

Citrobacter

+
Violet (medium colored
Violet (medium colored







freundii


colonies) with a clear ring
colonies) with a clear ring


18
I5a

NA

Salmonella


Cream colored colonies
Cream colored colonies







manhattan



19
I5a

NA

Escherichia coli

+
Violet (very dark colored
Pale violet (light colored








colonies) with no ring
colonies) with no ring


20
I5a
DAB
2:1

Escherichia coli

+
Violet (very dark colored
Cream colored colonies








colonies) with no ring
with no ring


21
I5a
DAB
1:1

Escherichia coli

+
Violet (medium colored
Cream colored colonies








colonies) with a clear ring
with no ring


22
I5a
MDAB
2:1

Escherichia coli

+
Violet (very dark colored
Violet (light colored colonies)








colonies) with no ring
with a clear ring


23
I5a
MDAB
1:1

Escherichia coli

+
Violet (very dark colored
Violet (medium colored








colonies) with no ring
colonies) with a clear ring


24
I5a

NA

Salmonella


Cream colored colonies
Cream colored colonies







manhattan



25
I5a
MDAB
1:1

Salmonella


Cream colored colonies
Cream colored colonies







manhattan



26
I9a

NA

Escherichia coli

+
Cream to olive colored









colonies


27
I9a
MDAB
1:1

Escherichia coli

+
Red colored colonies



28
I9a
MDAB
1:1

Salmonella


Cream colored colonies








enteritidis



29
I10a

NA

Escherichia coli

+
Cream to olive colored









colonies


30
I10a
MDAB
1:1

Escherichia coli

+
Cream to olive colored








colonies


31
I10a
MDAB
1:1

Salmonella


Cream colored colonies








enteritidis



32
I11a

NA

Escherichia coli

+
Cream to olive colored









colonies


33
I11a
MDAB
1:1

Escherichia coli

+
Red to brown colored








colonies


34
I11a
MDAB
1:1

Salmonella


Cream colored colonies








enteritidis



35
I12a

NA

Escherichia coli

+
Cream to olive colored









colonies


36
I12a
MDAB
1:1

Escherichia coli

+
Brown colored colonies


37
I12a
MDAB
1:1

Salmonella


Cream colored colonies








enteritidis






DAB: 4-(Dimethylamino)benzaldehyde


MDAB: 2-Methoxy-4-(dimethylamino)benzaldehyde


b-gal: beta-D-galactosidase


−: absent


+: present













TABLE IVa







Color, fluorescence and localization of various IO stains on microbial plating media


Bacterial colonies after 24 h on Nutrient Agar containing


150 mg/l substrate and 100 mg/l IPTG











E. coli


S. enteritidis




















eS: b-gal
+



I19a
1-(2-Benzoylphenyl)-1H-indol-3-yl-β-D-
C
yellow-orange
+




galactopyranoside
F
yellow
+





L

+
NA




G

+
+


I17a
1-(2-Acetylphenyl)-5-bromo-4-chloro-
C
yellow-orange
+




1H-indol-3-yl-β-D-galactopyranoside
F







L

+
NA




G

+
+


I20a
1-(2-Benzoylphenyl)-4-chloro-1H-indol-
C
orange
+/−




3-yl-β-D-galactopyranoside
F
orange
+/−





L

cryst.
NA




G

+
+


I13a
1-(2-Formylphenyl)-1H-indol-3-yl-β-D-
C
cream-orange
+/−




galactopyranoside
F







L

+




G

+
+


I10a
1-[2-(Methoxycarbonyl)phenyl]-1H-
C
yellow-green
+




indol-3-yl-β-D-galactopyranoside
F
green
+





L


NA




G

+
+


I28a
5-Bromo-4-chloro-1-[2-(2,4-dimethoxy-
C
orange
+




benzoyl)phenyl]-1H-indol-3-yl-β-D-
F
(red)
+/−




galactopyranoside
L

+
NA




G

+
+


I26a
4-Chloro-1-[2-(2,4-dimethoxy-
C
yellow-orange
+




benzoyl)phenyl]-1H-indol-3-yl-β-D-
F
orange
+/−




galactopyranoside
L

+
NA




G

+
+


I12a
5-Bromo-4-chloro-1-[2-(methoxy-
C
yellow-green
+/−




carbonyl)phenyl]-1H-indol-3-yl-β-D-
F
green
+/−




galactopyranoside
L


NA




G

+
+


I11a
6-Chloro-1-[2-(methoxy-
C
yellow-green
+




carbonyl)phenyl]-1H-indol-3-yl-β-D-
F
green
+




galactopyranoside
L


NA




G

+
+


I29a
6-Chloro-1-[2-(5-carboxyl-
C
red
+




furanoyl)phenyl]-1H-indol-3-yl-β-D-
F






galactopyranoside
L






G

+
+


I30a
6-Chloro-1-(2-furanoylphenyl)-1H-
C
dark orange
++




indol-3-yl-β-D-galactopyranoside
F
orange-red
+/−





L

+/−




G

+
+


I23a
6-Chloro-1-(2-benzoyl-5-chlorophenyl)-
C
yellow
+
NA



1H-indol-3-yl-β-D-galactopyranoside
F
green-yellow
+
NA




L

+
NA




G

+
NA


I18a
1-(2-Acetyl-5-methoxyphenyl)-1H-
C
light yellow
+




indol-3-yl-β-D-galactopyranoside
F
green
+/−





L

+/−
NA




G

+
+


I24a
1-(2-Benzoyl-5-methoxyphenyl)-1H-
C
dark yellow
+




indol-3-yl-β-D-galactopyranoside
F
yellow-green
+





L

+/−
NA




G

+
+


I14a
1-(2-Acetylphenyl)-1H-indol-3-yl-β-D-
C
light yellow
+




galactopyranoside
F







L

+
NA




G

+
+





C: Color of colonies


F: Fluorescence of colonies


G: Growth of colonies


L: Localization of stain on colonies


eS: External stimulus


b-gal: beta-D-galactosidase


NA: not applicable


−: absent


+/−: weak


+: strong


++: very strong













TABLE IVb





IO staining of colonies of beta-D-galactosidase positive/negative bacteria


Bacterial colonies after 24 h on Nutrient Agar containing


150 mg/l beta-D-galactosidase indicator and 100 mg/l IPTG




















I16a
I21a
I22a
I25a























eS
C
F

C
F

C
F

C
F



Species
Strain
b-gal
y
g
G
y
y-g
G
o
o
G
y
o
G






Aeromonas hydrophila

292
+
+
+
+
+
+
+
+/−
+/−
+
+
+/−
+



Citrobacter freundii

181
+
+
+
+
+
+
+
+
+/−
+
+
+
+



Enterobacter aerogenes

242
+
+
+
+
+
+
+
+
+/−
+
+
+
+



Enterobacter cloacae

245
+
+
+
+
+
+
+
+
+/−
+
+
++
+



Escherichia coli (O157:H7)

60
+
+
+
+
+
+
+
+
+/−
+
++
++
+



Escherichia coli

61
+
+
+
+
+
+
+
+
+/−
+
++
++
+



Escherichia coli

270
+
+
+
+
++
+
+
+
+/−
+
++
++
+



Klebsiella pneumoniae

164
+
+
+
+
+
+
+
+
+/−
+
+
+
+



Serratia marcescens

40
+
+
+
+
++
+
+
+
+/−
+
+
+/−
+



Staphylococcus intermedius

31
+
+/−
+/−
+/−
+/−
+/−
+/−



+/−
+/−
+



Staphylococcus saprophyticus

273
+
+
+
+
+
+
+



+/−
+/−
+



Salmonella bongori

81
+
+/−
+/−
+
+/−
+/−
+
+/−

+
+/−
+/−
+



Salmonella illa

73
+


+


+


+


+



Shigella dysenteriae Serovar 1

131
+/−


+


+


+


+



Shigella sonnei

133
+/−
+
+
+
+
+
+
+
+/−
+
+
++
+



Yersinia enterocolitica

175
+/−


+

+/−
+


+


+



Salmonella enteritidis

43



+


+


+


+



Bacillus subtilis

65



+


+/−





+



Listeria monocytogenes (4b)

290



+/−


+/−





+/−



Pseudomonas aeruginosa

168


+1
+

+1
+

+1
+

+1
+



Shigella boydii

135



+


+


+


+



Staphylococcus aureus

2



+/−


+/−



+/−2

+



Streptococcus agalactiae

195



+/−


+/−





+/−


















I4a



I28a
I27a
I31a
(Control)























eS
C
F

C
F

C
F

C
F



Species
Strain
b-gal
o
o
G
y
o
G
r
r
G
b

G






Aeromonas hydrophila

292
+
+/−

+
+
+
+
+

+
+

+



Citrobacter freundii

181
+
+
+/−
+
+
+
+
+
+/−
+
+

+



Enterobacter aerogenes

242
+
+
+/−
+
+
+
+
+
+/−
+
++

+



Enterobacter cloacae

245
+
+
+/−
+
++
++
+
+
+/−
+
++

+



Escherichia coli (O157:H7)

60
+
+
+/−
+
++
++
+
+
+/−
+
++

+



Escherichia coli

61
+
+
+/−
+
++
++
+
+
+/−
+
++

+



Escherichia coli

270
+
++
+/−
+
++
++
+
+
+/−
+
++

+



Klebsiella pneumoniae

164
+
+
+/−
+
+
+
+
+
+/−
+
++

+



Serratia marcescens

40
+
+/−

+
+
+
+
+

+
+

+



Staphylococcus intermedius

31
+
+
+/−
+


+/−
+

+
+

+



Staphylococcus saprophyticus

273
+
+/−

+
+/−
+/−
+
+

+
+

+



Salmonella bongori

81
+
+/−

+
+/−
+/−
+
+/−

+
+/−

+



Salmonella illa

73
+


+


+


+


+



Shigella dysenteriae Serovar 1

131
+/−


+


+


+


+



Shigella sonnei

133
+/−
+
+/−
+
+
++
+
+
+/−
+
+

+



Yersinia enterocolitica

175
+/−


+
+/−

+
+/−

+


+



Salmonella enteritidis

43



+


+


+


+



Bacillus subtilis

65



+/−


+


+


+



Listeria monocytogenes (4b)

290



+/−


+/−


+/−


+/−



Pseudomonas aeruginosa

168


+1
+

+1
+


+

+1
+



Shigella boydii

135



+


+


+


+



Staphylococcus aureus

2



+/−


+/−


+
y2

+



Streptococcus agalactiae

195



+/−


+/−


+/−


+/−





C: Color of colonies


F: Fluorescence of colonies


G: Growth of colonies


y: yellow


g: green


o: orange


r: red


b: blue


p: pink


−: absent


+/−: weak/variable


+: strong


++: very strong



1blue autofluorescence




2
S. aureus natural color














TABLE IVc





IO staining of colonies of bacteria producing


various biomarker enzymes







Bacterial colonies after 24 h on Nutrient Agar containing


0.45 mM beta-D-Glucuronidase Indicator











I3f



I21f
(control)

















eS
C
F

C




Species
Strain
glucuronidase
y
y-o
G
p
F
G






Escherichia coli

61
+
+
+/−
+
+

+



Escherichia coli

62
+
+
+/−
+
+

+



Escherichia coli

270
+
+
+/−
+
+

+



Klebsiella

164



+


+



pneumoniae











Bacterial colonies after 24 h on Nutrient Agar containing


150 mg/l alpha-D-Glucosidase Indicator









I21e














eS
C
F



Species
Strain
a-glucosidase
y
y-g
G






Enterobacter sakazakii

141
+
+
+/−
+



Enterobacter sakazakii

142
+
+
+/−
+



Enterobacter aerogenes

242



+



Enterobacter cloacae

245



+



Shigella sonnei

133



+



Escherichia coli

270



+










Bacterial colonies after 24 h on Nutrient Agar containing


0.52 mM C1-Esterase Indicator











I4c



I19c
(control)

















eS
C
F

C
F



Species
Strain
c1-esterase
y
y
G
b

G






Klebsiella pneumoniae

164

+
*
+
+

+



Escherichia coli

270

+/−
*
+


+/−



Bacillus cereus

289

++
*
+













Bacterial colonies after 24 h on Tryptic Soy Agar containing


0.78 mM PC PLC Indicator, 3.2 g/l BSA, 0.05% Tween80


and 5 mM MnCl2











I4d



I25d
(control)

















eS
C
F

C
F



Species
Strain
plc
y
y-g
G
b

G






Bacillus cereus

51
+
+
++
+
+/−

+



Bacillus cereus

289
+
+
++
+


+



Bacillus cereus

191
+
+
++
+
+/−

+



Bacillus cereus

192
+
++
++
+
++

+



Bacillus mycoides

64
+
+
++
+
+

+



Bacillus thuringiensis

66
+
+
++
+
+/−

+



Escherichia coli

61
+/−
+/−
+/−
+
+

+



Escherichia coli

270
+/−
+/−
+/−
+
+/−

+



Listeria monocytogenes

290
+


+


+


(4b)



Pseudomonas aeruginosa

168
+
y-g1
b2
+
y-g1
b2
+





*: diffuse background due to some precipitation of substrate



1natural color, same on agar without substrate




2natural fluorescence, same on agar without substrate



I21f: 1-(2-Benzoylphenyl)-6-chloro-1H-indol-3-yl-beta-D-glucuronide sodium salt


I3f: 6-Chloro-1H-indol-3-yl-beta-D-glucuronide sodium salt


I21e: 1-(2-Benzoylphenyl)-6-chloro-1H-indol-3-yl-alpha-D-glucopyranoside


I19c: 1-(2-Benzoylphenyl)-1H-indol-3-yl acetate


I4c: 5-Bromo-4-chloro-1H-indol-3-yl acetate


I25d: 1-[2-(2,4-Dimethoxybenzoyl)phenyl]-1H-indol-3-yl choline phosphate


I4d: 5-Bromo-4-chloro-1H-indol-3-yl choline phosphate


eS: External Stimulus


glucuronidase: beta-D-glucuronidase


a-glucosidase: alpha-D-glucosidase


plc: phosphatidyl choline phospholipase c


C: Color of colonies


F: Fluorescence of colonies


G: Growth of colonies


y: yellow


g: green


o: orange


r: red


b: blue


p: pink


−: absent


+/−: weak/variable


+: strong


++: very strong













TABLE IVd







IN and IO concurrent staining of bacterial colonies


Nutrient Agar containing beta-D-galactosidase


IO indicator I21a and IN indicator I4h












Species
Strain
eS: b-gal
eS: b-glu
C
G






Escherichia coli

270
+

y
+



Klebsiella pneumoniae

164
+
+
g
+



Enterobacter aerogenes

242
+
+
g
+



Enterococcus faecalis

210

+
b
+





I21a: 1-(2-Benzoylphenyl)-6-chloro-1H-indol-3-yl-beta-D-galactopyranoside


I4h: 5-Bromo-4-chloro-1H-indol-3-yl-beta-D-glucopyranoside


IO: 10H-indolo[1,2-a]indole staining


IN: Indigo staining


eS: External Stimulus


b-gal: beta-D-galactosidase


b-glu: beta-D-glucosidase


−: absent


+/−: weak/variable


+: strong


y: yellow


g: green


b: blue













TABLE IVe







IN and IO staining of bacterial colonies under


anaerobic conditions


Nutrient Agar plates containing various beta-D-galactosidase


indicators anaerobically incubated with E. coli














Indicator
Type/System
C
I
L
D
S
G





I21a
IO
y
+
+
+/−
0.7 mm
+


I22a
IO
o-r
+
++

0.5 mm
+


I27a
IO
y-o
+
+
+/−
  1 mm
+


I31a
IO
o-r
+
+/−
+
0.8 mm
+


I4a 
IN
b
+/−

++
pinpoint
+/−





IN: Indigo staining


IO: 10H-indolo[1,2-a]indole staining


C: Color of colonies


I: Intensity of color


L: Localization on colonies


D: Diffusion around colonies


S: Size of colonies


G: Growth of colonies


−: absent


+/−: weak/variable


+: strong


++: very strong


I21a: 1-(2-Benzoylphenyl)-6-chloro-1H-indol-3-yl-beta-D-galactopyranoside


I22a: 1-(2-Benzoylphenyl)-5-bromo-4-chloro-1H-indol-3-yl-beta-D-galactopyranoside


I27a: 6-Chloro-1-[2-(2,4-dimethoxybenzoyl)phenyl)-1H-indol-3-yl-beta-D-galactopyranoside


I31a: 6-Chloro-1-[2-(N-methylpyrrole-2-carbonyl)phenyl]-1H-indol-3-yl-beta-D-galactopyranoside


I4a: 5-Bromo-4-chloro-1H-indol-3-yl-beta-D-galactopyranoside


y: yellow


r: red


b: blue


o: orange













TABLE IVf







IO staining of bacterial colonies on Blood Agar plates



Klebsiella pneumoniae colonies after 24 h on Blood



Agar containing 150 mg/l I21a and 100 mg/l IPTG











Color of




Indicator
colonies
Color of colonies
Growth






white/visible
UV (366 nm)



I21a
Yellow
Yellow-orange on a dark background
+



Gray
Very weak bluish in front of dark
+




background (hardly visible)





IO: 10H-indolo[1,2-a]indole


I21a: 1-(2-Benzoylphenyl)-6-chloro-1H-indol-3-yl-beta-D-galactopyranoside


−: absent


+: strong













TABLE IVg







IO staining of fungal colonies


Agar plates containing indicator I21g













eS:




Species
Strain
galactosamidase
Color
Growth






Candida albicans

304
+
Yellow
+/−



Candida krusei

305

Cream
+/−



Saccharomyces cerevisiae

306

Cream
+/−





IO: 10H-indolo[1,2-a]indole


I21g: 1-(2-Benzoylphenyl)-6-chloro-1H-indol-3-yl-N-acetyl-beta-D-galactosaminide


−: absent


+/−: weak/variable


+: strong





Claims
  • 1. An indicator system for detecting an external stimulus, comprising an indicator compound of the general formula
  • 2. The indicator system according to claim 1, wherein R5 is hydrogen and the acceptor compound (B) is 2-methoxy-4-(N,N-dimethylamino)benzaldehyde.
  • 3. The indicator system according to claim 1, wherein LG is selected from the group consisting of beta-D-galactopyranoside, tert-butyldimethylsilyloxy (TBDMS), acetate, choline phosphate, alpha-D-glucopyranoside, beta-D-glucuronide sodium salt, N-acetyl-beta-D-galactosaminide and beta-D-glucopyranoside.
  • 4. The indicator system according to claim 1, wherein R10 is selected from the group consisting of hydrogen, methyl, methoxy, phenyl, DMP, CFur, Fur, NPyr, wherein:
  • 5. A method of detecting an external stimulus in a region of interest, comprising: providing the region of interest with an indicator system; andmonitoring for a signal from a signalophore species formed as a consequence of said external stimulus;whereinsaid indicator system is as defined in claim 1 with the X-LG moiety being susceptible to conversion by action of said external stimulus, said conversion leading to formation of a signalogen species comprising an enolic moiety wherein XH is bound to a carbon atom that is bound to a further carbon atom by a double bond; said signalophore species being formed by reaction of said enolic moiety with an acceptor moiety selected from carbonyl, imino and thiocarbonyl.
  • 6. The method according to claim 5, wherein said acceptor moiety is a carbonyl moiety.
  • 7. The method according to claim 6, wherein said carbonyl moiety is provided by adding an acceptor compound of the general formula
  • 8. The method according to claim 7, wherein the acceptor compound (B) is 2-methoxy-4-(N,N-dimethylamino)benzaldehyde.
  • 9. The method according to claim 5, wherein said acceptor moiety is a part of said indicator molecule.
  • 10. The method according to claim 5, wherein, if R5 is hydrogen, the signalophore species is a 2-benzylideneindoline with the structural formula
  • 11. The method according to claim 5, carried out under substantially oxygen-depleted conditions.
  • 12. A method of preparing an indicator compound of the general formula
  • 13. A compound of structural formula
  • 14. A compound according to claim 13, with the exception of the following compounds:
  • 15. Use of a compound according to claim 13 in an indicator system for detecting an external stimulus.
Priority Claims (1)
Number Date Country Kind
09159639.5 May 2009 EP regional
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/EP10/56212 5/6/2010 WO 00 11/23/2011